- •Pediatric Retina
- •Preface
- •1: Development of the Retina
- •1.1 To suppose that the eye . . . could have been formed by natural selection, seems, I freely confess, absurd . . .1
- •1.2 Good order is the foundation of all things2
- •1.3 All that you touch you Change. All that Change Changes you3
- •1.4 Men are born with two eyes, but only one tongue, in order that they should see twice as much as they say4
- •1.7 More than Meets the Optic Vesicle6
- •1.9 Focusing on the Fovea: A Marvel of Development
- •1.10 Nature and Books belong to the eyes that see them7
- •References
- •2: Anatomy and Physiology of the Retina
- •2.1 Introduction
- •2.2 Anatomy of the Retina
- •2.2.2 Cellular Organization of the Retina
- •2.2.2.1 Retinal Pigment Epithelium
- •2.2.2.2 Photoreceptors
- •2.2.2.3 Interneuron Cells
- •2.2.2.4 Ganglion Cells
- •2.2.2.5 Glial Cells
- •2.2.3.1 Bruch’s Membrane
- •2.2.3.2 Retinal Pigment Epithelium
- •2.2.3.3 Photoreceptor Layer
- •2.2.3.4 External Limiting Membrane
- •2.2.3.5 Outer Nuclear Layer
- •2.2.3.6 Outer Plexiform Layer
- •2.2.3.7 Inner Nuclear Layer
- •2.2.3.8 Inner Plexiform Layer
- •2.2.3.9 Ganglion Cell Layer
- •2.2.3.10 Nerve Fiber Layer
- •2.2.5 Blood Supply of the Retina
- •2.2.5.1 Choroidal Circulation
- •2.2.5.2 Hyaloid Circulation
- •2.2.5.3 Retinal Circulation
- •2.2.5.5 Regulation of Blood Flow to the Retina
- •2.2.6 Optic Nerve
- •2.2.6.1 Physiology and Development
- •2.3 Physiology of the Retina
- •2.3.1 The Retinal Pigment Epithelium
- •2.3.3 Image-Forming Visual System
- •2.3.3.1 Detection of Photons by Visual Pigment in the Photoreceptor Cell
- •2.3.3.2 Light Activation of the Photopigment
- •2.3.4 Nonimage-Forming Visual System
- •2.3.5 Targets of Retinal Projections
- •2.4 Retinal Development
- •2.4.2 Foveal Development
- •References
- •3.1 Full-Field ERG
- •3.1.1.1 Rod Response
- •3.1.1.2 Standard Combined Response
- •3.1.1.3 Oscillatory Potentials
- •3.1.1.4 Single-Flash Cone Response
- •3.1.1.5 Light-Adapted Flicker Response
- •3.1.2 Repeat Variability
- •3.1.4 Clinical Uses of the Full-Field ERG
- •3.1.4.2 Stationary Night Blindness
- •3.1.4.3 Enhanced S-Cone Syndrome
- •3.1.4.4 Leber Congenital Amaurosis
- •3.2 Focal and Multifocal ERG
- •References
- •4: Retinopathy of Prematurity (ROP)
- •4.1 Introduction
- •4.2 History
- •4.3 Classification
- •4.4 Incidence
- •4.5 Natural History and Prognosis
- •Disease with Little or No Risk
- •Disease with Moderate Risk
- •Disease with High Risk
- •4.6 Pathogenesis
- •4.7 Screening
- •4.8 Management
- •4.9 Prevention
- •4.10 Interdiction
- •4.11 Corrective Therapy
- •4.12 Mitigation
- •4.13 Medicolegal Considerations
- •4.14 Conclusion
- •References
- •5: Optic Nerve Malformations
- •5.1 Optic Nerve Hypoplasia
- •5.1.1 Overview/Clinical Significance
- •5.1.2 Classification
- •5.1.3 Genetics
- •5.1.4 Pathophysiology
- •5.1.5 Natural History
- •5.1.6 Diagnosis
- •5.1.7 Treatment
- •5.2 Morning Glory Disc Anomaly
- •5.2.1 Overview/Clinical Significance
- •5.2.2 Classification
- •5.2.3 Genetics
- •5.2.4 Pathophysiology
- •5.2.5 Natural History
- •5.2.6 Diagnosis
- •5.2.7 Treatment
- •5.2.8 Associations and Complications
- •5.3 Optic Nerve Head Pits
- •5.3.1 Introduction
- •5.3.2 Overview with Clinical Significance
- •5.3.3 Classification
- •5.3.4 Genetics
- •5.3.5 Pathophysiology
- •5.3.6 Incidence
- •5.3.8 Diagnosis and Diagnostic Aids
- •5.3.9 Treatment
- •5.3.10 Complications and Associations
- •5.4 Optic Disc Coloboma
- •5.4.1 Introduction
- •5.4.2 Genetics
- •5.4.3 Pathophysiology
- •5.4.4 Natural History and Prognosis
- •5.4.5 Diagnosis and Diagnostic Aids
- •5.4.6 Treatment
- •5.5 Optic Nerve Tumor
- •5.5.1 Glioma
- •5.5.1.1 Introduction
- •5.5.2 Overview with Clinical Significance
- •5.5.2.1 Optic Nerve Glioma
- •5.5.2.2 Optic Chiasmal Glioma
- •5.5.3 Pathophysiology
- •5.5.4 Incidence
- •5.5.6 Diagnosis
- •5.5.7 Treatment
- •5.5.8 Social and Family Impact
- •5.6.1 Introduction
- •5.6.3 Pathophysiology
- •5.6.4 Incidence
- •5.6.5 Diagnosis and Diagnostic Aids
- •5.6.6 Treatment
- •5.7 Melanocytoma
- •5.7.1 Introduction
- •5.7.2 Pathophysiology
- •5.7.3 Natural History and Prognosis
- •5.7.4 Diagnosis and Diagnostic Aids
- •5.7.5 Treatment
- •5.8 Metastatic Tumors: Leukemia
- •5.8.1 Introduction
- •5.8.2 Pathophysiology
- •5.8.3 Natural History and Prognosis
- •5.8.4 Treatment
- •5.8.4.1 Other Elevated Disc Anomalies
- •5.9 Drusen
- •5.9.1 Introduction
- •5.9.2 Pathophysiology
- •5.9.3 Natural History and Prognosis
- •5.9.4 Diagnosis and Diagnostic Aids
- •5.10 Hyperopia
- •5.11 Persistence of the Hyaloid System
- •5.12 Tilted Disc
- •5.12.1 Introduction
- •5.12.2 Historical Context
- •5.12.3 Overview with Clinical Significance
- •5.12.4 Genetics
- •5.12.5 Pathophysiology
- •5.12.6 Incidence
- •5.13 Myelinated Nerve Fibers
- •5.13.1 Introduction
- •5.13.2 Genetics
- •5.13.3 Pathophysiology
- •5.13.4 Incidence
- •References
- •6.1.1 Albinism
- •6.1.1.1 Disorders Specific to Melanosomes
- •Hermansky–Pudlak Syndrome
- •Chediak–Higashi Syndrome
- •Diagnosis and Treatment
- •6.1.2 Gyrate Atrophy
- •6.1.3 Cystinosis
- •6.1.3.1 Primary Hyperoxaluria
- •6.2.1 The Gangliosidoses
- •6.2.2 GM1 Gangliosidosis
- •6.2.3 GM2 Gangliosidosis
- •6.2.3.1 Tay–Sachs Disease
- •6.2.4 Sandhoff Disease
- •6.2.5 Niemann–Pick Disease
- •6.2.7 Type C Niemann–Pick Disease
- •6.2.8 Fabry Disease
- •6.2.9 Farber Lipogranulomatosis
- •6.2.10 The Mucopolysaccharidoses
- •6.2.10.1.1 MPS I H: Hurler Syndrome
- •6.2.10.1.2 MPS I S: Scheie Syndrome
- •6.2.10.1.3 MPS I H/S: Hurler–Scheie Syndrome
- •6.2.10.2 MPS II: Hunter Syndrome
- •6.2.10.3 MPS III: Sanfilippo Syndrome
- •6.2.10.4 MPS IV: Morquio Syndrome
- •6.2.10.5 MPS VI: Maroteaux–Lamy Syndrome
- •6.2.10.6 MPS VII: Sly Syndrome
- •6.3 Disorders of Glycoprotein
- •6.3.1 Sialidosis
- •6.4 Disorders of Peroxisomes
- •6.4.1 Refsum Disease
- •References
- •7: Phacomatoses
- •7.1 Introduction
- •7.2 Neurofibromatosis
- •7.2.1 Neurofibromatosis Type 1
- •7.2.1.1 Introduction
- •7.2.1.2 Historical Context
- •7.2.1.3 Overview with Clinical Significance
- •7.2.1.4 Genetics
- •7.2.1.5 Natural History and Prognosis
- •7.2.1.6 Signs and Symptoms
- •7.2.2 Ocular Manifestations
- •7.2.2.1 Lisch Nodules
- •7.2.2.2 Optic Pathway Glioma
- •7.2.2.3 Neurofibroma of the Eyelid and Orbit
- •7.2.3 Systemic Manifestations
- •7.2.3.1 Café-au-lait Spot
- •7.2.3.2 Neurofibroma
- •7.2.3.3 CNS Abnormality
- •Diagnosis and Diagnostic Aids
- •Treatment
- •Social and Family Impact
- •7.2.4 Neurofibromatosis Type 2 (NF2)
- •7.2.4.1 Introduction
- •7.2.4.2 Historical Context
- •7.2.4.3 Overview with Clinical Significance
- •7.2.4.4 Classification
- •7.2.4.5 Genetics
- •7.2.4.6 Incidence
- •7.2.4.7 Natural History and Prognosis
- •7.2.4.8 Signs and Symptoms
- •Ocular Findings
- •Systemic Findings
- •Vestibular Schwannoma
- •Diagnosis and Diagnostic Aids
- •Treatment
- •Complications and Associations
- •Social and Family Impact
- •7.3 Von Hippel–Lindau Disease
- •7.3.1 Introduction
- •7.3.2 Historical Context
- •7.3.3 Overview with Clinical Significance
- •7.3.4 Classification
- •7.3.5 Genetics
- •7.3.6 Pathophysiology
- •7.3.7 Incidence
- •7.3.8 Natural History and Prognosis
- •7.3.9 Signs and Symptoms
- •7.3.9.1 Ocular Manifestations
- •Retinal Capillary Hemangioma
- •7.3.9.2 Systemic Manifestations
- •CNS Hemangioma
- •Renal Cell Carcinoma
- •Pheochromocytoma
- •Pancreatic Cystadenoma and Islet Cell Tumors
- •Epididymis Cystadenoma
- •7.3.10 Diagnosis and Diagnostic Aids
- •7.3.10.1 Coats’ Disease
- •7.3.10.2 Racemose Hemangioma
- •7.3.10.3 Retinal Cavernous Hemangioma
- •7.3.10.4 Retinal Macroaneurysm
- •7.3.10.5 Vasoproliferative Tumor
- •7.3.11 Fluorescein Angiography
- •7.3.12 Indocyanine Green Angiography
- •7.3.13 Ultrasonography
- •7.3.14 Magnetic Resonance Imaging
- •7.3.16 Treatment
- •7.3.17 Observation
- •7.3.18 Laser Photocoagulation
- •7.3.19 Cryotherapy
- •7.3.21 Plaque Radiotherapy
- •7.3.22 Proton Beam Radiotherapy
- •7.3.24 Enucleation
- •7.3.25 Social and Family Impact
- •7.4 Tuberous Sclerosis Complex
- •7.4.1 Introduction
- •7.4.2 Historical Context
- •7.4.3 Overview with Clinical Significance
- •7.4.4 Classification
- •7.4.5 Genetics
- •7.4.6 Incidence
- •7.4.7 Natural History and Prognosis
- •7.4.8 Signs and Symptoms
- •7.4.8.1 Ocular Findings
- •Retinal Astrocytic Hamartoma
- •7.4.8.2 Systemic Findings
- •Dermatologic Manifestations
- •Neurologic Manifestations
- •Visceral Manifestations
- •Diagnosis and Diagnostic Aids
- •Treatment
- •Social and Family Impact
- •7.5 Sturge-Weber Syndrome
- •7.5.1 Introduction
- •7.5.2 Historical Context
- •7.5.3 Overview with Clinical Significance
- •7.5.4 Incidence
- •7.5.5 Genetics
- •7.5.6 Pathophysiology
- •7.5.7 Natural History and Prognosis
- •7.5.8 Signs and Symptoms
- •7.5.8.1 Diffuse Choroidal Hemangioma
- •7.5.8.2 Glaucoma
- •7.5.8.3 Nevus Flammeus
- •7.5.8.4 Leptomeningeal Hemangiomatosis
- •7.5.8.5 Diagnosis and Diagnostic Aids
- •7.5.8.6 Treatment
- •7.5.8.7 Social and Family Impact
- •7.6 Wyburn-Mason Syndrome
- •7.6.1 Introduction
- •7.6.2 Historical Context
- •7.6.3 Overview with Clinical Significance
- •7.6.4 Classification
- •7.6.5 Genetics
- •7.6.6 Pathophysiology
- •7.6.7 Natural History and Prognosis
- •7.6.8 Signs and Symptoms
- •7.6.8.1 Ocular Findings
- •Retinal Arteriovenous Malformation
- •Diagnosis and Diagnostic Aids
- •Treatment
- •7.6.9 Ataxia Telangiectasia
- •7.6.9.1 Introduction
- •7.6.9.2 Historical Context
- •7.6.9.3 Overview with Clinical Significance
- •7.6.9.4 Classification
- •7.6.9.5 Genetics
- •7.6.9.6 Incidence
- •7.6.9.7 Natural History and Prognosis
- •7.6.9.8 Signs and Symptoms
- •7.6.9.9 Diagnosis and Diagnostic Aids
- •7.6.9.10 Treatment
- •7.6.9.11 Social and Family Impact
- •7.7 Retinal Caverous Hemangioma
- •7.7.1 Introduction
- •7.7.2 Historical Context
- •7.7.3 Overview with Clinical Significance
- •7.7.4 Genetics
- •7.7.5 Incidence
- •7.7.6 Natural History and Prognosis
- •7.7.7 Signs and Symptoms
- •7.7.7.1 Ocular Findings
- •7.7.7.2 Systemic Findings
- •Cutaneous Lesions
- •Diagnosis and Diagnostic Aids
- •Treatment
- •References
- •8.1 Introduction
- •8.2 Embryology
- •8.3 Clinical Findings
- •8.3.1 Primary anomalies
- •8.3.2 Secondary findings
- •8.3.3 Differential Diagnosis
- •8.3.3.1 Ancillary Tests
- •8.3.3.2 Prognosis
- •8.3.3.3 Treatment
- •8.4 Practical Surgical Issues
- •8.4.1 The Posterior Surgery
- •References
- •9.1 Introduction
- •9.2 Retinoblastoma Presentation SOP
- •9.2.1 Objective
- •9.2.2 Applicability
- •9.2.3 Scope
- •9.2.4 Clinical Significance
- •9.2.5 Procedures
- •9.2.6 Consequences
- •9.2.7 Related SOPs
- •9.3.1 Objectives
- •9.3.2 Applicability
- •9.3.3 Scope
- •9.3.4 Clinical Significance
- •9.3.5 Procedures
- •9.3.6 Consequences
- •9.3.7 Related SOPs
- •9.4 Genetics of Retinoblastoma SOP
- •9.4.1 Objective
- •9.4.2 Applicability
- •9.4.3 Scope
- •9.4.4 Clinical Significance
- •9.4.5 Procedure
- •9.4.6 Consequences
- •9.4.7 Related SOPs
- •9.5 Screening of Relatives SOP
- •9.5.1 Objective
- •9.5.2 Applicability
- •9.5.3 Scope
- •9.5.4 Clinical Significance
- •9.5.5 Procedure
- •9.5.6 Consequences
- •9.5.7 Related SOPs
- •9.6 Treatment SOP
- •9.7 Enucleation Indications SOP
- •9.7.1 Objective
- •9.7.2 Applicability
- •9.7.3 Scope
- •9.7.4 Clinical Significance
- •9.7.5 Procedure
- •9.7.6 Consequences
- •9.7.7 Related SOPs
- •9.8 Enucleation Technique SOP
- •9.8.1 Objectives
- •9.8.2 Applicability
- •9.8.3 Scope
- •9.8.4 Clinical Significance
- •9.8.5 Procedure
- •9.8.6 Consequences
- •9.8.7 Related SOPs
- •9.9.1 Objectives
- •9.9.2 Applicability
- •9.9.3 Scope
- •9.9.4 Clinical Significance
- •9.9.5 Procedure
- •9.9.6 Consequences
- •9.9.7 Related SOPs
- •9.10 Histopathology Analysis SOP
- •9.10.1 Objectives
- •9.10.2 Applicability
- •9.10.3 Scope
- •9.10.4 Clinical Significance
- •9.10.5 Procedure
- •9.10.6 Consequences
- •9.10.7 Related SOPs
- •9.11 Cryotherapy SOP
- •9.11.1 Objectives
- •9.11.2 Applicability
- •9.11.3 Scope
- •9.11.4 Clinical Significance
- •9.11.5 Procedure
- •9.11.6 Consequences
- •9.11.7 Related SOPs
- •9.12 Laser Therapy SOP
- •9.12.1 Objective
- •9.12.2 Applicability
- •9.12.3 Scope
- •9.12.4 Clinical Significance
- •9.12.5 Procedure
- •9.12.6 Consequences
- •9.12.7 Related SOPs
- •9.13 Local Chemotherapy SOP
- •9.13.1 Objectives
- •9.13.2 Applicability
- •9.13.3 Scope
- •9.13.4 Clinical Significance
- •9.13.5 Procedure
- •9.13.6 Consequences
- •9.13.7 Related SOPs
- •9.14 Systemic Chemotherapy SOP
- •9.14.1 Objectives
- •9.14.2 Applicability
- •9.14.3 Scope
- •9.14.4 Clinical Significance
- •9.14.5 Procedure
- •9.14.6 Consequences
- •9.14.7 Related SOPs
- •9.15 Radiation SOP
- •9.15.1 Objective
- •9.15.2 Applicability
- •9.15.3 Scope
- •9.15.4 Clinical Significance
- •9.15.5 Procedure
- •9.15.6 Consequences
- •9.15.7 Related SOPs
- •9.16.1 Objective
- •9.16.2 Applicability
- •9.16.3 Scope
- •9.16.4 Clinical Significance
- •9.16.5 Procedure
- •9.16.6 Consequences
- •9.16.7 Related SOPs
- •9.17 Follow-Up SOP
- •9.17.1 Objective
- •9.17.2 Applicability
- •9.17.3 Scope
- •9.17.4 Clinical Significance
- •9.17.5 Procedure
- •9.17.6 Consequences
- •9.17.7 Related SOPs
- •References
- •10: Coats’ Disease
- •10.1 Overview
- •10.3 Clinical Aspects
- •10.3.1 Demographics
- •10.3.2 Ocular Findings
- •10.4 Pathology and Pathophysiology
- •10.5 Genetics
- •10.6 Natural History
- •10.8 Management
- •10.9 Systemic Associations
- •10.10 Social and Family Impact
- •10.11 Future Treatment
- •References
- •11.1.1 Stargardt Macular Dystrophy
- •11.1.1.1 Clinical Features: STGD
- •11.1.1.2 Diagnostic Features: STGD
- •11.1.1.3 Differential Diagnosis: STGD
- •11.1.1.4 Inherited Forms: STGD
- •11.1.2 Best Macular Dystrophy
- •11.1.2.1 Clinical Features: BMD
- •11.1.2.2 Diagnostic Features: BMD
- •11.1.2.3 Differential Diagnosis: BMD
- •11.1.2.4 Inherited Forms: BMD
- •11.1.3 Juvenile X-Linked Retinoschisis
- •11.1.3.1 Clinical Features: JXRS
- •11.1.3.2 Diagnostic Features: JXRS
- •11.1.3.3 Differential Diagnosis: JXRS
- •11.1.3.4 Inherited Forms: JXRS
- •11.2.2 Molecular Genetic Testing
- •11.2.3.1 ABCR
- •11.2.3.2 ELOVL4
- •11.2.3.3 PROM1
- •11.2.3.4 BEST-1
- •11.3.1 STGD
- •11.3.3 JXRS
- •11.4.1 STGD Models
- •11.4.2 BMD Models
- •11.4.3 JXRS Models
- •11.5 Phenotypic Diversity
- •11.6 Potential Therapeutics for Juvenile Macular Degenerations
- •References
- •12: Generalized Inherited Retinal Dystrophies
- •12.1 Introduction
- •12.2 Historical Context
- •12.4.1 Retinitis Pigmentosa
- •12.4.1.1 Overview with Clinical Significance
- •12.4.1.2 Genetics
- •12.4.1.3 Pathophysiology
- •12.4.1.4 Prevalence
- •12.4.1.5 Patient History and Evaluation
- •12.4.1.6 Diagnostic Testing
- •12.4.1.7 Treatment
- •12.4.2 Congenital Leber Amaurosis
- •12.4.2.1 Genetics
- •12.4.2.2 Pathophysiology
- •12.4.2.3 Incidence/Prevalence
- •12.4.2.4 Natural History and Prognosis
- •12.4.2.5 Diagnostic Testing
- •12.4.2.6 Treatment
- •12.4.3.1 Genetics
- •12.4.3.2 Pathophysiology
- •12.4.3.3 Incidence
- •12.4.3.4 Natural History and Prognosis
- •12.4.3.5 Diagnostic Testing
- •12.4.3.6 Treatment
- •12.4.3.7 Achromatopsia
- •12.4.4.1 Genetics
- •12.4.4.2 Pathophysiology
- •12.4.4.3 Incidence
- •12.4.4.4 Evaluation and Prognosis
- •12.4.4.5 Diagnostic Testing
- •12.4.4.6 Treatment
- •12.4.4.7 Complications and Disease Associations
- •12.4.4.8 Social Considerations
- •References
- •13: Vitreoretinal Dystrophies
- •13.1 Stickler Syndrome
- •13.1.1 Introduction
- •13.1.2 Historical Context
- •13.1.3 Overview with Clinical Significance
- •13.1.4 Classification
- •13.1.5 Genetics
- •13.1.6 Pathophysiology
- •13.1.7 Incidence
- •13.1.8 Natural History and Prognosis of STK (Signs, Symptoms, Timing, etc.)
- •13.1.9 Diagnosis and Diagnostic Aids
- •13.1.10 Treatment
- •13.1.11 Complications and Associations
- •13.1.12 Social and Family Impact
- •13.2 Wagner Disease
- •13.2.1 Introduction
- •13.2.2 Historical Context
- •13.2.3 Overview with Clinical Significance
- •13.2.4 Classification
- •13.2.5 Genetics
- •13.2.6 Pathophysiology
- •13.2.7 Incidence
- •13.2.9 Diagnosis and Diagnostic Aids
- •13.2.10 Treatment
- •13.2.11 Complications and Associations
- •13.2.12 Social and Family Impact
- •13.3 Juvenile X-Linked Retinoschisis
- •13.3.1 Introduction
- •13.3.2 Historical Context
- •13.3.3 Overview with Clinical Significance
- •13.3.4 Classification
- •13.3.5 Genetics
- •13.3.6 Pathophysiology
- •13.3.7 Incidence
- •13.3.9 Diagnosis and Diagnostic Aids
- •13.3.10 Treatment
- •13.3.11 Complications and Associations
- •13.3.12 Social and Family Impact
- •13.4.1 Introduction
- •13.4.2 Historical Context
- •13.4.3 Overview with Clinical Significance
- •13.4.4 Classification
- •13.4.5 Genetics
- •13.4.6 Pathophysiology
- •13.4.7 Incidence
- •13.4.9 Diagnosis and Diagnostic Aids
- •13.4.10 Treatment
- •13.4.11 Complications and Associations
- •13.4.12 Social and Family Impact
- •13.5 Goldmann-Favre Syndrome
- •13.5.1 Introduction
- •13.5.2 Historical Context
- •13.5.3 Overview with Clinical Significance
- •13.5.4 Classification
- •13.5.5 Genetics
- •13.5.6 Pathophysiology
- •13.5.7 Incidence
- •13.5.9 Diagnosis and Diagnostic Aids
- •13.5.10 Treatment
- •13.5.11 Complications and Associations
- •13.5.12 Social and Family Impact
- •13.6 Incontinentia Pigmenti (IP)
- •13.6.1 Introduction
- •13.6.2 Historical Context
- •13.6.3 Overview with Clinical Significance
- •13.6.4 Classification
- •13.6.5 Genetics
- •13.6.6 Pathophysiology
- •13.6.7 Incidence
- •13.6.9 Diagnosis and Diagnostic Aids
- •13.6.10 Treatment
- •13.6.11 Complications and Associations
- •13.6.12 Social and Family Impact
- •13.7.9 Diagnosis and Diagnostic Aids
- •13.7.10 Treatment
- •13.7.11 Complications and Associations
- •13.7.12 Social and Family Impact
- •References
- •14.1 Introduction
- •14.2 Clinical Course
- •14.3 Differential Diagnosis
- •14.4 Pathology
- •14.5 Selected Conditions
- •14.6 Treatment
- •References
- •15: Proliferative Retinopathies in Children
- •15.1 Introduction
- •15.2 Historical Context
- •15.3 Overview with Clinical Significance
- •15.4 Classification
- •15.5 Genetics (table 15.1)
- •15.5.1 Pathophysiology
- •15.5.2 Natural History and Prognosis
- •15.5.3 Diabetes Mellitus
- •15.5.4 Sickle Cell Disease
- •15.5.5 Incontinentia Pigmenti
- •15.6 Complications and Associations
- •15.7 Social and Family Impact
- •References
- •16: Infectious Diseases of the Pediatric Retina
- •16.1 Introduction
- •16.2 Protozoal Diseases
- •16.2.1 Toxoplasma gondii
- •16.2.1.1 Life Cycle and Transmission
- •16.2.1.2 Epidemiology
- •16.2.1.3 Congenital Infection
- •16.2.1.4 Ocular Disease
- •16.2.1.5 Immunocompromised Patients
- •16.2.1.6 Diagnosis of Ocular Toxoplasmosis
- •16.2.1.7 Treatment
- •16.2.1.8 Treatment in Special Situations
- •16.3 Viral Diseases
- •16.3.1 Cytomegalovirus Retinitis
- •16.3.1.1 Congenital CMV Infection
- •16.3.1.2 Ocular Manifestations
- •16.3.1.3 Acquired CMV Infection
- •16.3.1.4 Ocular Disease
- •16.3.1.5 Pathology
- •16.3.1.6 Diagnosis
- •16.3.1.7 Therapy
- •16.3.2 Varicella Zoster Virus
- •16.3.2.1 Ocular Manifestations
- •16.3.3 Herpes Simplex Virus
- •16.3.3.1 Ocular Disease
- •16.3.4 Acute Retinal Necrosis
- •16.3.4.1 Clinical Presentation
- •16.3.4.2 Diagnosis
- •16.3.4.3 Treatment
- •16.3.5 HIV Infection
- •16.3.5.1 Ocular Manifestations
- •16.3.5.2 Noninfectious HIV Microangiopathy
- •16.3.6 Measles
- •16.3.7 Rubella
- •16.3.7.1 Congenital Rubella Syndrome
- •16.4 Parasitic Infection
- •16.4.1 Toxocariasis
- •16.4.1.1 Ocular Involvement
- •16.4.1.2 Diagnosis
- •16.4.1.3 Differential Diagnosis
- •16.4.1.4 Treatment
- •16.4.2 Onchocerciasis
- •16.4.2.1 Ocular Manifestations
- •16.4.2.2 Diagnosis and Treatment
- •16.5 Bacterial Diseases
- •16.5.1 Syphilis
- •16.5.1.1 Clinical Manifestations
- •16.5.1.2 Congenital Syphilis
- •16.5.1.3 Acquired Syphilis
- •16.5.1.4 Diagnosis
- •16.5.1.5 Syphilis and AIDS
- •16.5.1.6 Treatment
- •16.5.2 Tuberculosis
- •16.5.2.1 Ocular Manifestation
- •16.5.2.2 Diagnosis
- •16.5.2.3 Tuberculosis and AIDS
- •16.5.2.4 Treatment
- •16.6 Rare Childhood Bacterial Diseases
- •16.6.1 Brucellosis
- •16.6.2 Leptospirosis
- •16.6.3 Lyme Disease
- •16.6.4 Cat Scratch Disease
- •16.7 Fungal Disease
- •16.7.1 Histoplasmosis
- •16.7.1.1 Ocular Histoplasmosis Syndrome (OHS)
- •16.7.1.2 Diagnosis and Treatment
- •16.7.2 Fungal Endophthalmitis
- •16.7.2.1 Endogenous Fungal Endophthalmitis
- •Candidiasis
- •Ocular Features
- •Diagnosis and Treatment
- •Rare Causes of Endogenous Endophthalmitis
- •Aspergillosis
- •Cryptococcosis
- •Histoplasmosis
- •Pneumocystis carinii
- •North American Blastomycosis
- •Coccidiomycosis
- •Other Fungal Infections
- •16.7.2.2 Exogenous Fungal Endophthalmitis
- •16.8 Rickettsial Disease
- •References
- •17.1 Introduction
- •17.2 Age of Victims
- •17.4 Perpetrators
- •17.5 Brain Injury
- •17.6 Skeletal Injuries
- •17.7 Acute Ophthalmic Findings
- •17.8 Dating of Retinal Hemorrhages
- •17.9 Treatment of Retinal Hemorrhages
- •17.10 Late Ophthalmic Findings
- •17.13 The Role of the Ophthalmologist
- •References
- •18: Pediatric Retinal Trauma
- •18.1 Introduction
- •18.2 Epidemiology
- •18.3 Etiology of Trauma
- •18.3.1 Sports
- •18.3.2 Assault
- •18.3.3 Birth Trauma
- •18.3.4 Projectile Injury
- •18.3.5 Miscellaneous Causes
- •18.3.6 Sympathetic Ophthalmia
- •18.4 Closed Globe Injuries
- •18.4.1 Traumatic Macular Hole
- •18.4.2 Commotio Retinae
- •References
- •19: Pediatric Uveitis
- •19.1 General Introduction
- •19.2 Classification
- •19.3 Social and Family Impact
- •19.4 Noninfectious
- •19.4.1 Juvenile Rheumatoid Arthritis
- •19.4.1.1 Historical Context
- •19.4.1.2 Clinical Findings/Natural History
- •Subtypes of JRA (Table 19.2) .
- •Screening Guidelines
- •Pathophysiology
- •Diagnosis/Treatment
- •Genetics
- •Complications
- •19.4.2 HLA-B27-Associated Uveitis
- •19.4.2.1 Historical Context
- •19.4.2.2 Clinical Findings/Natural History
- •Pathophysiology/Genetics
- •Diagnosis/Treatment/Complications
- •19.4.3 Tub ulointerstitial Nephritis and Uveitis (TINU)
- •19.4.3.1 Historical Context
- •19.4.3.2 Clinical Findings/Natural History
- •Pathophysiology/Genetics
- •Diagnosis/Treatment/Complications
- •19.4.4 Sarcoidosis
- •19.4.4.1 Historical Context
- •19.4.4.2 Clinical Findings/Natural History
- •Pathophysiology
- •Genetics
- •Diagnosis/Treatment/Complications
- •19.4.5 Pars Planitis
- •19.4.5.1 Historical Context
- •19.4.5.2 Clinical Findings/Natural History
- •Pathophysiology/Genetics
- •Diagnosis
- •Treatment
- •Step 1
- •Step 2
- •Step 3
- •Step 4
- •Complications
- •19.5 Infectious
- •19.5.1 Toxoplasmosis
- •19.5.1.1 Historical Context/Pathophysiology
- •19.5.1.2 Clinical Findings/Natural History
- •Genetics
- •Diagnosis/Treatment/Complications
- •19.5.2 Toxocariasis
- •19.5.2.1 Historical Context/Pathophysiology
- •19.5.2.2 Clinical Findings/Natural History
- •Genetics
- •Diagnosis/Treatment/Complications
- •19.5.3 Bartonella henselae
- •19.5.3.1 Historical Context/Pathophysiology
- •19.5.3.2 Clinical Findings/Natural History
- •Genetics
- •Diagnosis/Treatment/Complications
- •19.5.4.1 Historical Context/Pathophysiology
- •19.5.4.2 Clinical Findings/Natural History
- •Genetics
- •Diagnosis/Treatment/Complications
- •19.5.5 Congenital Ocular Syphilis
- •19.5.5.1 Historical Context/Pathophysiology
- •19.5.5.2 Clinical Findings/Natural History
- •Genetics
- •Diagnosis/Treatment/Complications
- •References
- •Index
26 |
F. Gonzalez-Fernandez |
|
|
associated with astrocytes expressing VEGF mRNA. VEGF mRNA is also associated with the ganglion cell layer. These findings raise the possibility that in the incipient fovea, the ganglion cells are hypoxic, suggesting that the foveal depression could be an adaptation of the neural retina to a limited blood supply.
It is not well understood how the relationship between the perifoveal capillaries and the foveal depression is established. Taking a new approach to the problem of the formation of the foveal pit, Springer et al (2004). used virtual engineering models to identify mechanical mechanisms that could contribute to its formation [324]. Their data suggest that the foveal pit emerges as a consequence of the avascular zone. The absence of blood vessels makes the tissue within the avascular zone more elastic and malleable than the surrounding vascularized retina. Their models predict that the pit is formed because an absence of vasculature makes the inner retinal tissue of the avascular zone deformable.
As mentioned above, a characteristic of the fovea is the dense packing and elongation of photoreceptors in the central area. The mechanism responsible for these structural features is largely unknown. Any model would have to provide an explanation how rod photoreceptors are excluded from the fovea, and what triggers and maintains the high cone density. Cones are among the first retinal cells to become postmitotic at a particular location, and rods are among the last. The histogenesis of the retina follows a spatiotemporal gradient with the more central region differentiating into a laminated structure ahead of the more peripheral parts. As a result of the above considerations, the foveal cones are there among the first retinal cells to differentiate closely following the central ganglion and horizontal cells. Interestingly, when the central cones first differentiate at 11–12 weeks gestational age, they are relatively large, cuboidal in shape (~7 mm soma diameter), and arranged in a regular array with a spatial density of 14,200 cell/ mm2. By 24 weeks gestation, the density increases to 38,000 cones/mm2, and the soma diameter reduces to 4 mm. The process is indeed protracted as the final density of 100,000–324,000 cones/mm2 in humans is not reached until between 3 and 4 years of life [325]. This accumulation of foveal cones appears to occur in the absence of local cell divisions [313, 326]. As the above changes occur, the overall area of the foveolar cone mosaic contracts. The overall area of the mosaic is about 5 times greater during early development than in the adult [312, 325]. The available data suggest that the
accumulation of cones in the central retina arises through their displacement toward the foveolar cone mosaic (reviewed in [317]). The mechanism for the exclusion of rods from the fovea is also unclear. One explanation is that by the time significant numbers of rods are being generated during development, the incipient fovea has become overcrowded with cones physically excluding rods due to limited space. An alternative more attractive model is that specific factors inhibit the generation of rods in the fovea. This idea is consistent with the finding that foveal cones are present in the foveal photoreceptor mosaic early in development [319].
In summary, the fovea is a marvel of development. We are only just beginning to obtain a glimpse into the mechanisms responsible for its formation. The factors and molecular signaling pathways orchestrating the development of this remarkable structure have yet to be uncovered. Our understanding of the histogenesis ofthefoveaisthereforefarfromcomplete.Nevertheless, the critical importance of this specialized region for optimal resolving power and its vulnerability in conditions such as age-related macular degeneration provide compelling reasons to give more attention to uncovering the mystery of its development.
1.10 Nature and Books belong to the eyes that see them7
Our understanding of the embryology of the retina has come from diverse experimental systems ranging from drosophila to mice. The field illustrates how new techniques combined with clear thinking, hypothesisdriven research, long hours in the laboratory, and good colleagues can persuade the retina to reveal her secrets. Notwithstanding the significant advances in the field, there is the danger that we might conclude that everything important has already been found out, and everything significant is already known. However, as we enter the postgenome era, the main central questions regarding the mechanisms responsible for the development of the retina, and the pathophysiology of its diseases, appear as yet surprisingly unresolved!
Particularly exciting is the availability of new systems that provide a marriage between the classic embryological approaches and modern genetic
7Ralph Waldo Emerson (1803–1882)
1 Development of the Retina |
27 |
|
|
technical strategies. For example, only a few years ago, the amphibian retina, which has proved so useful in classical embryological studies, was found to be very amenable to genetic manipulations (Figs. 1.20 and 1.21). The future is bright for this and other novel experimental approaches. We are therefore entering a new era where understandings from ocular embryology will have even more of the center stage in understanding the pediatric retina in both health and disease.
Reviewing what is known about the development of the retina is a humbling experience. We can only conclude that so little is really understood about the obvious important key questions. Of course, the reader should come away with an understanding of the significant contributions that others have made. More importantly, we should appreciate that the truly important insights and discoveries still await inquisitive minds.
Fig. 1.20 A young metamorphosed transgenic Nieuwkoop– Faber stage 66 Xenopus laevis (left) compared to a nontransgenic animal of the same age (right). The animals were photographed under white light in (a). (b) Shows fluorescence from green fluorescent protein (GFP) expressed in the photoreceptors of the transgenic animal (arrow). The fluorescence appears to be coming from the lens, but is actually originating from the retina behind it. Amphibians, such as Xenopus, provide important model systems to study ocular development. This is due to the feasibility of performing microdissections, and organ-
culture studies in these animals. Such manipulations are feasible because each cell is supported by an intercellular food droplet. The embryo does not require placenta or yoke sack, and is therefore accessible at all developmental stages. Their retinas are organized in a manner similar to our own, and the large size of the retinal neurons facilitate cellular studies. Finally, recent technical advances have allowed routine preparation of transgenic Xenopus allowing genetic strategies to be added to the experimental biologist’s tool chest. The images in this figure represent unpublished data from the author’s laboratory
28 |
F. Gonzalez-Fernandez |
|
|
Fig. 1.21 Confocal fluorescence photomicrographs of stage 35 Xenopus retina. (a) The expression of green fluorescent protein (GFP) is directed to developing photoreceptors using the rod opsin promoter. GFP fluorescence provides a way to visualize the cells recognizing the opsin promoter (generous gift of Dr. Barry E. Knox). Indirect immunofluorescence is used to localize rod opsin to the developing rod outer segments (secondary antibody is labeled with Texas Red) (arrowheads). (b) Higher magnification of the GFP expressing cells. Arrows, lipid droplets; asterisk, nonGFP expressing cone photoreceptors; bracket, region of cell containing nucleus. Further information regarding the use of Xenopus as an experimental system, contacts, and the government initiatives to stimulate this important field may be found at www.nih. gov/science/models/xenopus/index.html. The images in this figure represent unpublished data from the author’s laboratory
Acknowledgements We extend an apology to the authors of the many excellent papers that could not be cited directly because of space constraints. Dr Gonzalez-Fernandez holds the Ira G. Olmsted Ross and Elizabeth P. Ross Chair of Ophthalmic Pathology. The Work was supported in part by Merit Review Award I01BX007080 from the Biomedical Laboratory Research & Development Service of the Veterans Affairs Office of Research and Development, RO1 EY09412, R24 EY016662 core instrumentation grant, and an unrestricted grant from Research to Prevent Blindness.
References
1. Abramov, I., Gordon, J., Hendrickson, A., Hainline, L., Dobson, V., LaBossiere, E.: The retina of the newborn human infant. Science 217, 265–267 (1982)
2. Glass, A.S., Dahm, R.: The zebrafish as a model organism for eye development. Ophthalmic. Res. 36, 4–24 (2004)
3. Malicki, J., Jo, H., Wei, X., Hsiung, M., Pujic, Z.: Analysis of gene function in the zebrafish retina. Methods 28, 427– 438 (2002)
4. Malicki, J.: Development of the retina. Methods Cell. Biol. 59, 273–299 (1999)
5. Felsenfeld, A.L.: Defining the boundaries of zebrafish developmental genetics. Nat. Genet. 14, 258–263 (1996)
6. Moritz, O.L., Tam, B.M., Papermaster, D.S., Nakayama, T.: A functional rhodopsin-green fluorescent protein fusion protein localizes correctly in transgenic Xenopus laevis retinal rods and is expressed in a time-dependent pattern. J. Biol. Chem. 276, 28242–28251 (2001)
7. Tam, B.M., Moritz, O.L., Hurd, L.B., Papermaster, D.S.: Identification of an outer segment targeting signal in the COOH terminus of rhodopsin using transgenic Xenopus laevis. J. Cell. Biol. 151, 1369–1380 (2000)
8. Knox, B.E., Schlueter, C., Sanger, B.M., Green, C.B., Besharse, J.C.: Transgene expression in Xenopus rods. FEBS. Lett. 423, 117–121 (1998)
9. Jin, S., McKee, T.D., Oprian, D.D.: An improved rhodopsin/ EGFP fusion protein for use in the generation of transgenic Xenopus laevis. FEBS. Lett. 542, 142–146 (2003)
10.Hutcheson, D.A., Vetter, M.L.: Transgenic approaches to retinal development and function in Xenopus laevis. Methods 28, 402–410 (2002)
11.Hirsch, N., Zimmerman, L.B., Grainger, R.M.: Xenopus, the next generation: X. tropicalis genetics and genomics. Dev. Dyn. 225, 422–433 (2002)
12.Hirsch, N., Zimmerman, L.B., Gray, J., Chae, J., Curran, K.L., Fisher, M., Ogino, H., Grainger, R.M.: Xenopus tropicalis transgenic lines and their use in the study of embryonic induction. Dev. Dyn. 225, 522–535 (2002)
13.Ogura, T.: In vivo electroporation: a new frontier for gene delivery and embryology. Differentiation 70, 163–171 (2002)
14.Beck, C.W., Slack, J.M.: An amphibian with ambition: a new role for Xenopus in the 21st century. Genome Biol. 2, 1029.1021–1209.1025 (2001)
15.Sparrow, D.B., Latinkic, B., Mohun, T.J.: A simplified method of generating transgenic Xenopus. Nucelic Acids Res. 28, E12 (2000)
16.Ishibashi, S., Kroll, K.L., Amaya, E.: A method for generating transgenic frog embryos. In: Meth. Mol. Biol., 461, 447–466 (2008)
17.Slack, J.M.: Developmental biology. High hops of transgenic frogs. Nature 383, 765–766 (1996)
18.Land, M.F., Fernald, R.D.: The evolution of eyes. Ann. Rev. Neurosci. 15, 1–29 (1992)
19.Salvini-Plawen, L., Mayr, E.: In: Evolutionary biology. Hecht, M.K., Steere, W.C., Wallace, B. (eds.) Plenum, New York 10, 207-263 (1977)
20.Halder, G., Callaerts, P., Gehring, W.J.: New perspectives on eye evolution. Curr. Opin. Genet. Dev. 5, 602–609 (1995)
1 Development of the Retina |
29 |
|
|
21.Gehring, W.J.: The genetic control of eye development and its implications for the evolution of the various eye-types. Int. J. Dev. Biol. 46, 65–73 (2002)
22.Gehring, W.J.: Historical perspective on the development and evolution of eyes and photoreceptors. Int. J. Dev. Biol. 48, 707–717 (2004)
23.Treisman, J.E.: How to make an eye. Development 131, 3823–3827 (2004)
24.Land, M.F.: Compound eyes: old and new optical mechanisms. Nature 287, 681–686 (1980)
25.Saari, J.C.: Retinoids in photosensitive systems. In: Sporn, M.B., Roberts, A.B., Goodman, D.S. (eds.) The retinoids, pp. 351–385. Raven, New York (1994)
26.Saari, J.C.: Biochemistry of visual pigment regeneration: the Friedenwald lecture. Invest. Ophthalmol. Vis. Sci 41, 337– 348 (2000)
27.McBee, J.K., Palczewski, K., Baehr, W., Pepperberg, D.R.: Confronting complexity: the interlink of phototransduction and retinoid metabolism in the vertebrate retina. Prog. Retin. Eye Res. 20, 469–529 (2001)
28.Gonzalez-Fernandez, F.: Interphotoreceptor retinoid-binding protein–an old gene for new eyes. Vision Res. 43, 3021– 3036 (2003)
29.Gonzalez-Fernandez, F.: Evolution of the visual cycle: the role of retinoid-binding proteins. J. Endocrinol. 175, 75–88 (2002)
30.Hara, R., Hara, T., Tokunaga, F., Yoshizawa, T.: Photo chemistry of retinochrome. Photochem. Photobiol. 33, 883– 891 (1981)
31.Hara, T., Hara, R.: Cephalopod retinochrome. Methods Enzymol. 81, 827–833 (1982)
32.Messenger, J.B.: Comparative physiology and evolution of vision in invertebrates. Springer, Berlin (1981)
33.Ozaki, K., Terakita, A., Ozaki, M., Hara, R., Hara, T., HaraNishimura, I., Mori, H., Nishimura, M.: Molecular characterization and functional expression of squid retinal-binding protein. A novel species of hydrophobic ligand-binding protein. J. Biol. Chem. 269, 3838–3845 (1994)
34.Ozaki, K., Terakita, A., Hara, R., Hara, T.: Isolation and characterization of a retinal-binding protein from the squid retina. Vision Res. 27, 1057–1070 (1987)
35.Terakita, A., Hara, R., Hara, T.: Retinal-binding protein as a shuttle for retinal in the rhodopsin-retinochrome system of the squid visual cells. Vision Res. 29, 639–652 (1989)
36.Lamb, T.D., Pugh, E.N.: Dark adaptation and the retinoid cycle of vision. Prog. Retina. Eye Res. 23, 307–380 (2004)
37.Mata, N., Radu, R., Clemmons, R., Travis, G.: Isomerization and oxidation of vitamin a in cone-dominant retinas. A novel pathway for visual-pigment regeneration in daylight. Neuron 36, 69–80 (2002)
38.Kumar, J.P., Moses, K.: Eye specification in Drosophila: perspectives and implications. Semin. Cell Dev. Biol. 12, 469–474 (2001)
39.Kumar, J.P.: Signalling pathways in Drosophila and vertebrate retinal development. Nat. Rev. Genet. 2, 846–857 (2001)
40.Kumar, J.P., Moses, K.: Expression of evolutionarily conserved eye specification genes during Drosophila embryogenesis. Dev. Genes. Evol. 211, 406–414 (2001)
41.Sander, K., Faessler, P.E.: Introducing the Spemann-Mangold organizer: experiments and insights that generated a key concept in developmental biology. Int. J. Dev. Biol. 45, 1–11 (2001)
42.Hamburger, V.: Hilde Mangold, co-discoverer of the organizer. J. Hist. Biol. 17, 1–11 (1984)
43.Bouwmeester, T.: The Spemann-Mangold organizer: the control of fate specification and morphogenetic rearrangements during gastrulation in Xenopus. Int. J. Dev. Biol. 45, 251–258 (2001)
44.De Robertis, E.M., Wessely, O., Oelgeschlager, M , Brizuela, B., Pera, E., Larrain, J., Abreu, J., Bachiller, D.: Molecular mechanisms of cell-cell signaling by the Spemann-Mangold organizer. Int. J. Dev. Biol. 45, 189–197 (2001)
45.Weinstein, D.C., Hemmati-Brivanlou, A.: Neural induction. Annu. Rev. Cell Dev. Biol. 15, 411–433 (1999)
46.Niehrs, C.: Head in the WNT: the molecular nature of Spemann’s head organizer. Trends Genet. 15, 314–319 (1999)
47.Streit, A., Stern, C.D.: Neural induction. A bird’s eye view. Trends Genet. 15, 20–24 (1999)
48.Fini, M.E., Strissel, K.J., West-Mays, J.A.: Perspectives on eye development. Dev. Genet. 20, 175–185 (1997)
49.Chow, R.L., Lang, R.A.: Early eye development in vertebrates. Annu. Rev. Cell Dev. Biol. 17, 255–296 (2001)
50.Saha, M.S., Servetnick, M., Grainger, R.M.: Vertebrate eye development. Curr. Opin. Genet. Dev. 2, 582–588 (1992)
51.Jarman, A.P.: Developmental genetics: vertebrates and insects see eye to eye. Curr. Biol. 10, R857–R859 (2000)
52.Rapaport, D.H., Patheal, S.L., Harris, W.A.: Cellular compe-
tence plays a role in photoreceptor differentiation in the developing Xenopus retina. J. Neurobiol. 49, 129–141 (2001)
53.Harris, W.A., Messersmith, S.L.: Two cellular inductions involved in photoreceptor determination in the Xenopus retina. Neuron 9, 357–372 (1992)
54.Ohnuma, S., Hopper, S., Wang, K.C., Philpott, A., Harris, W.A.: Co-ordinating retinal histogenesis: early cell cycle exit enhances early cell fate determination in the Xenopus retina. Development 129, 2435–2446 (2002)
55.Wessely, O., De Robertis, E.M.: Neural plate patterning by secreted signals. Neuron 33, 489–491 (2002)
56.Saha, M.S., Spann, C.L., Grainger, R.M.: Embryonic lens induction: more than meets the optic vesicle. Cell Differ. Dev. 28, 153–171 (1989)
57.Grainger, R.M., Henry, J.J., Saha, M.S., Servetnick, M.: Recent progress on the mechanisms of embryonic lens formation. Eye 6(Pt 2), 117–122 (1992)
58.Lupo, G., Andreazzoli, M., Gestri, G., Liu, Y., He, R.Q., Barsacchi, G.: Homeobox genes in the genetic control of eye development. Int. J. Dev. Biol. 44, 627–636 (2000)
59.Servetnick, M., Grainger, R.M.: Changes in neural and
lens competence in Xenopus |
ectoderm: evidence |
for |
|
an autonomous |
developmental |
timer. Development |
112, |
177–188 (1991) |
|
|
|
60.Grainger, R.M., Herry, J.J., Henderson, R.A.: Reinvestigation of the role of the optic vesicle in embryonic lens induction. Development 102, 517–526 (1988)
61.Henry, J.J., Grainger, R.M.: Inductive interactions in the spatial and temporal restriction of lens-forming potential in embryonic ectoderm of Xenopus laevis. Dev. Biol. 124, 200–214 (1987)
62.Spemann, H.: Embryonic development and induction. Yale University, New Haven (1938)
63.Graham, A.: The origin of dorsoventral patterning of the vertebrate nervous system. Trends Genet. 13, 463–465 (1997)
30 |
F. Gonzalez-Fernandez |
|
|
64.Chan, A., Lakshminrusimha, S., Heffner, R., GonzalezFernandez, F.: Histogenesis of retinal dysplasia in trisomy 13. Diagn. Pathol. 2, 48 (2007)
65.Roessler, E., Muenke, M.: Midline and laterality defects: left and right meet in the middle. Bioessays 23, 888–900 (2001)
66.Roessler, E., Muenke, M.: Holoprosencephaly: a paradigm for the complex genetics of brain development. J. Inherit. Metab. Dis. 21, 481–497 (1998)
67.Wallis, D.E., Muenke, M.: Molecular mechanisms of holoprosencephaly. Mol. Genet. Metab. 68, 126–138 (1999)
68.Golden, J.A.: Towards a greater understanding of the pathogenesis of holoprosencephaly. Brain Dev. 21, 513–521 (1999)
69.Muenke, M., Cohen Jr., M.M.: Genetic approaches to understanding brain development: holoprosencephaly as a model. Ment. Retard. Dev. Disabil. Res. Rev. 6, 15–21 (2000)
70.Yamada, S., Uwabe, C., Fujii, S., Shiota, K.: Phenotypic variability in human embryonic holoprosencephaly in the Kyoto Collection. Birth Defects Res. Part A Clin. Mol. Teratol. 70, 495–508 (2004)
71.Thakur, S., Singh, R., Pradhan, M., Phadke, S.R.: Spectrum of holoprosencephaly. Indian J. Pediatr. 71, 593–597 (2004)
72.Nanni, L., Schelper, R.L., Muenke, M.T.: Molecular genetics of holoprosencephaly. Front Biosci. 5, D334–D342 (2000)
73.Johnson, V.P.: Holoprosencephaly: a developmental field defect. Am. J. Med. Genet. 34, 258–264 (1989)
74.Belloni, E., Muenke, M., Roessler, E., Traverso, G., SiegelBartelt, J., Frumkin, A., Mitchell, H.F., Donis-Keller, H., Helms, C., Hing, A.V., et al.: Identification of Sonic hedgehog as a candidate gene responsible for holoprosencephaly. Nat. Genet. 14, 353–356 (1996)
75.Ahlgren, S.C., Bronner-Fraser, M.: Inhibition of sonic hedgehog signaling in vivo results in craniofacial neural crest cell death. Curr. Biol. 9, 1304–1314 (1999)
76.Pasquier, L., Dubourg, C., Blayau, M., Lazaro, L., Le Marec, B., David, V., Odent, S.: A new mutation in the six-domain of SIX3 gene causes holoprosencephaly. Eur. J. Hum. Genet. 8, 797–800 (2000)
77.Wallis, D., Muenke, M.: Mutations in holoprosencephaly. Hum. Mutat. 16, 99–108 (2000)
78.Schell-Apacik, C., Rivero, M., Knepper, J.L., Roessler, E., Muenke, M., Ming, J.E.: SONIC HEDGEHOG mutations causing human holoprosencephaly impair neural patterning activity. Hum. Genet. 113, 170–177 (2003)
79.Roessler, E., Muenke, M.: How a Hedgehog might see holoprosencephaly. Hum. Mol. Genet. 12 Spec No 1, R15–R25 (2003)
80.Ming, J.E., Kaupas, M.E., Roessler, E., Brunner, H.G., Golabi, M., Tekin, M., Stratton, R.F., Sujansky, E., Bale, S.J., Muenke, M.: Mutations in PATCHED-1, the receptor for SONIC HEDGEHOG, are associated with holoprosencephaly. Hum. Genet. 110, 297–301 (2002)
81.Kinsman, S.L., Plawner, L.L., Hahn, J.S.: Holoprosenceph aly: recent advances and new insights. Curr. Opin. Neurol. 13, 127–132 (2000)
82.Gripp, K.W., Wotton, D., Edwards, M.C., Roessler, E., Ades, L., Meinecke, P., Richieri-Costa, A., Zackai, E.H., Massague, J., Muenke, M., Elledge, S.J.: Mutations in TGIF cause holoprosencephaly and link NODAL signalling to human neural axis determination. Nat. Genet. 25, 205–208 (2000)
83.Dubourg, C., Lazaro, L., Pasquier, L., Bendavid, C., Blayau, M., Le Duff, F., Durou, M.R., Odent, S., David, V.: Molecular screening of SHH, ZIC2, SIX3, and TGIF genes in patients with features of holoprosencephaly spectrum: Mutation review and genotype-phenotype correlations. Hum. Mutat. 24, 43–51 (2004)
84.Edison, R., Muenke, M.: The interplay of genetic and environmental factors in craniofacial morphogenesis: holoprosencephaly and the role of cholesterol. Congenit. Anom (Kyoto). 43, 1–21 (2003)
85.Cohen Jr., M.M., Shiota, K.: Teratogenesis of holoprosencephaly. Am. J. Med. Genet. 109, 1–15 (2002)
86.Aguilella, C., Dubourg, C., Attia-Sobol, J., Vigneron, J., Blayau, M., Pasquier, L., Lazaro, L., Odent, S., David, V.: Molecular screening of the TGIF gene in holoprosencephaly: identification of two novel mutations. Hum. Genet. 112, 131–134 (2003)
87.Roessler, E., Belloni, E., Gaudenz, K., Jay, P., Berta, P., Scherer, S.W., Tsui, L.C., Muenke, M.: Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat. Genet. 14, 357–360 (1996)
88.Nybakken, K., Perrimon, N.: Hedgehog signal transduction: recent findings. Curr. Opin. Genet. Dev. 12, 503–511 (2002)
89.Cooper, M.K., Porter, J.A., Young, K.E., Beachy, P.A.: Teratogen-mediated inhibition of target tissue response to Shh signaling. Science 280, 1603–1607 (1998)
90.Lanoue, L., Dehart, D.B., Hinsdale, M.E., Maeda, N , Tint, G.S., Sulik, K.K.: Limb, genital, CNS, and facial malformations result from gene/environment-induced cholesterol deficiency: further evidence for a link to sonic hedgehog. Am. J. Med. Genet. 73, 24–31 (1997)
91.Roessler, E., Belloni, E., Gaudenz, K., Vargas, F., Scherer, S.W., Tsui, L.C., Muenke, M.: Mutations in the C-terminal domain of Sonic Hedgehog cause holoprosencephaly. Hum. Mol. Genet. 6, 1847–1853 (1997)
92.Weed, M., Mundlos, S., Olsen, B.R.: The role of sonic hedgehog in vertebrate development. Matrix Biol. 16, 53–58 (1997)
93.Kelley, R.L., Roessler, E., Hennekam, R.C., Feldman, G.L., Kosaki, K., Jones, M.C., Palumbos, J.C., Muenke, M.: Holoprosencephaly in RSH/Smith-Lemli-Opitz syndrome: does abnormal cholesterol metabolism affect the function of Sonic Hedgehog? Am. J. Med. Genet. 66, 478–484 (1996)
94.Gofflot, F., Hars, C., Illien, F., Chevy, F., Wolf, C., Picard, J.J., Roux, C.: Molecular mechanisms underlying limb anomalies associated with cholesterol deficiency during gestation: implications of Hedgehog signaling. Hum. Mol. Genet. 12, 1187–1198 (2003)
95.Porter, F.D.: Human malformation syndromes due to inborn errors of cholesterol synthesis. Curr. Opin. Pediatr. 15, 607– 613 (2003)
96.Kelley, R.I.: Inborn errors of cholesterol biosynthesis. Adv. Pediatr. 47, 1–53 (2000)
97. Roux, C., Wolf, C., Mulliez, N., Gaoua, W., Cormier, V., Chevy, F., Citadelle, D.: Role of cholesterol in embryonic development. Am. J. Clin. Nutr. 71, 1270S–1279S (2000)
98. Lee, J.D., Treisman, J.E.: Sightless has homology to transmembrane acyltransferases and is required to generate active Hedgehog protein. Curr. Biol. 11, 1147–1152 (2001)
99. Incardona, J.P., Roelink, H.: The role of cholesterol in Shh signaling and teratogen-induced holoprosencephaly. Cell Mol. Life Sci. 57, 1709–1719 (2000)
1 Development of the Retina |
31 |
|
|
100. Lewis, P.M., Dunn, M.P., McMahon, J.A., Logan, M., Martin, J.F., St-Jacques, B., McMahon, A.P.: Cholesterol modification of sonic hedgehog is required for long-range signaling activity and effective modulation of signaling by Ptc1. Cell 105, 599–612 (2001)
101. Zeng, X., Goetz, J.A., Suber, L.M., Scott Jr., W.J., Schreiner, C.M., Robbins, D.J.: A freely diffusible form of Sonic hedgehog mediates long-range signalling. Nature 411, 716–720 (2001)
102. Gritli-Linde, A., Lewis, P., McMahon, A.P., Linde, A.: The whereabouts of a morphogen: direct evidence for shortand graded long-range activity of hedgehog signaling peptides. Dev. Biol. 236, 364–386 (2001)
103. Goetz, J.A., Suber, L.M., Zeng, X., Robbins, D.J.: Sonic Hedgehog as a mediator of long-range signaling. Bioessays 24, 157–165 (2002)
104. Pepinsky, R.B., Zeng, C., Wen, D., Rayhorn, P., Baker, D.P., Williams, K.P., Bixler, S.A., Ambrose, C.M., Garber, E.A., Miatkowski, K., et al.: Identification of a palmitic acidmodified form of human Sonic hedgehog. J. Biol. Chem. 273, 14037–14045 (1998)
105. Taylor, F.R , Wen, D., Garber, E.A., Carmillo, A N., Baker, D.P., Arduini, R.M., Williams, K.P., Weinreb, P.H., Rayhorn, P., Hronowski, X., et al.: Enhanced potency of human Sonic hedgehog by hydrophobic modification. Biochemistry 40, 4359–4371 (2001)
106. Chuang, P.T., Kornberg, T.B.: On the range of hedgehog signaling. Curr. Opin. Genet. Dev. 10, 515–522 (2000)
107. Incardona, J.P., Gaffield, W., Kapur, R.P., Roelink, H.: The teratogenic Veratrum alkaloid cyclopamine inhibits sonic hedgehog signal transduction. Development 125, 3553–3562 (1998)
108. Incardona, J.P., Gaffield, W., Lange, Y., Cooney, A., Pentchev, P.G., Liu, S., Watson, J.A., Kapur, R.P, Roelink, H.: Cyclopamine inhibition of Sonic hedgehog signal transduction is not mediated through effects on cholesterol transport. Dev. Biol. 224, 440–452 (2000)
109.Hammerschmidt, M., Brook, A., McMahon, A.P.: The world according to hedgehog. Trends Genet. 13, 14–21 (1997)
110. Johnson, R.L., Scott, M.P.: New players and puzzles in the Hedgehog signaling pathway. Curr. Opin. Genet. Dev. 8, 450–456 (1998)
111. Traiffort, E., Dubourg, C., Faure, H., Rognan, D., Odent, S., Durou, M.R., David, V., Ruat, M.: Functional characterization of SHH mutations associated with holoprosencephaly. J. Biol. Chem. 279(41), 42889–42897 (2004)
112. Muenke, M., Gurrieri, F., Bay, C., Yi, D.H., Collins, A.L., Johnson, V.P., Hennekam, R.C., Schaefer, G.B., Weik, L., Lubinsky, M.S., et al.: Linkage of a human brain malformation, familial holoprosencephaly, to chromosome 7 and evidence for genetic heterogeneity. Proc. Natl. Acad. Sci. USA 91, 8102–8106 (1994)
113. Ming, J.E., Muenke, M.: Multiple hits during early embryonic development: digenic diseases and holoprosencephaly. Am. J. Hum. Genet. 71, 1017–1032 (2002)
114. Li, H., Tierney, C., Wen, L., Wu, J.Y., Rao, Y.: A single morphogenetic field gives rise to two retina primordia under the influence of the prechordal plate. Development 124, 603–615 (1997)
115. Adelmann, H.B.: Experimental studies on the development of the eye. I. The effect of the removal of median and lateral
areas of the anterior end of the urodelan neural plate on the development of the eyes (Triton teniatus and Amblystoma punctatum). J Comp Neurol 54, 249–290 (1929)
116. Yamamoto, Y., Stock, D.W., Jeffery, W.R.: Hedgehog signalling controls eye degeneration in blind cavefish. Nature 431, 844–847 (2004)
117.Anderson, R.M., Lawrence, A.R., Stottmann, R.W., Bachiller, D., Klingensmith, J.: Chordin and noggin promote organizing
centers of forebrain development in the mouse. Development 129, 4975–4987 (2002)
118. Golden, J.A., Bracilovic, A., McFadden, K.A., Beesley, J.S., Rubenstein, J.L., Grinspan, J.B.: Ectopic bone morphogenetic proteins 5 and 4 in the chicken forebrain lead to cyclopia and holoprosencephaly. Proc. Natl. Acad. Sci. USA 96, 2439–2444 (1999)
119. Kalter, H.: Cyclopia produced in a very early retinoic acid experiment. Teratology 46, 207–208 (1992)
120. Muller, F., Albert, S., Blader, P., Fischer, N., Hallonet, M., Strahle, U.: Direct action of the nodal-related signal cyclops in induction of sonic hedgehog in the ventral midline of the CNS. Development 127, 3889–3897 (2000)
121. Nasevicius, A., Ekker, S.C.: Effective targeted gene ‘knockdown’ in zebrafish. Nat. Genet. 26, 216–220 (2000)
122. Sampath, K., Rubinstein, A.L., Cheng, A.M., Liang, J.O., Fekany, K., Solnica-Krezel, L., Korzh, V., Halpern, M.E., Wright, C.V.: Induction of the zebrafish ventral brain and floorplate requires cyclops/nodal signalling. Nature 395, 185–189 (1998)
123. Gorlin, R.J.: Nevoid basal cell carcinoma (Gorlin) syndrome. Genet. Med. 6, 530–539 (2004)
124. Bale, A.E., Yu, K.P.: The hedgehog pathway and basal cell carcinomas. Hum. Mol. Genet. 10, 757–762 (2001)
125. Ingham, P.W.: The patched gene in development and cancer. Curr. Opin. Genet. Dev. 8, 88–94 (1998)
126. Wolter, M., Reifenberger, J., Sommer, C., Ruzicka, T., Reifenberger, G.: Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res. 57, 2581–2585 (1997)
127. Chidambaram, A., Dean, M.: Genetics of the nevoid basal cell carcinoma syndrome. Adv. Cancer Res. 70, 49–61 (1996)
128.Hahn, H., Wicking, C., Zaphiropoulous, P.G., Gailani, M.R., Shanley, S., Chidambaram, A., Vorechovsky, I., Holmberg, E., Unden, A.B., Gillies, S., et al.: Mutations of the human homolog of Drosophila patched in the nevoid basal cell car-
cinoma syndrome. Cell 85, 841–851 (1996)
129. Evans, D.G., Ladusans, E.J., Rimmer, S., Burnell, L.D., Thakker, N., Farndon, P.A.: Complications of the naevoid basal cell carcinoma syndrome: results of a population based study. J. Med. Genet. 30, 460–464 (1993)
130.Shanley, S., Ratcliffe, J., Hockey, A., Haan, E., Oley, C., Ravine, D., Martin, N., Wicking, C., Chenevix-Trench, G.:
Nevoid basal cell carcinoma syndrome: review of 118 affected individuals. Am. J. Med. Genet. 50, 282–290 (1994)
131. Manners, R.M., Morris, R.J., Francis, P.J., Hatchwell, E.: Microphthalmos in association with Gorlin’s syndrome. Br. J. Ophthalmol. 80, 378 (1996)
132. Reish, O., Gorlin, R.J., Hordinsky, M., Rest, E.B., Burke, B., Berry, S.A.: Brain anomalies, retardation of mentality and
32 |
F. Gonzalez-Fernandez |
|
|
growth, ectodermal dysplasia, skeletal malformations, Hirschsprung disease, ear deformity and deafness, eye hypoplasia, cleft palate, cryptorchidism, and kidney dysplasia/ hypoplasia (BRESEK/BRESHECK): new X-linked syndrome? Am. J. Med. Genet. 68, 386–390 (1997)
133. De Potter, P., Stanescu, D., Caspers-Velu, L., Hofmans, A.: Photo essay: combined hamartoma of the retina and retinal pigment epithelium in Gorlin syndrome. Arch. Ophthalmol. 118, 1004–1005 (2000)
134. Manzi, G., Magli, A., Pignalosa, B., Liguori, G.: The Gorlin-Goltz syndrome: case report. Ophthalmologica 200, 104–106 (1990)
135. Boutimzine, N., Laghmari, A., Karib, H., Karmane, M., Bencherif, M., Albouzidi, A., Cherkaoui, O., Mohcine, Z.: Gorlin-Goltz phacomatosis: ophthalmological aspects in one case. J. Fr. Ophtalmol. 23, 180–186 (2000)
136. De Jong, P.T., Bistervels, B., Cosgrove, J., de Grip, G., Leys, A., Goffin, M.: Medullated nerve fibers. A sign of multiple basal cell nevi (Gorlin’s) syndrome. Arch. Ophthalmol. 103, 1833–1836 (1985)
137. Wallace, V.A., Raff, M.C.: A role for Sonic hedgehog in axon-to-astrocyte signalling in the rodent optic nerve. Development 126, 2901–2909 (1999)
138. Jensen, A.M., Wallace, V.A.: Expression of Sonic hedgehog and its putative role as a precursor cell mitogen in the developing mouse retina. Development 124, 363–371 (1997)
139. Wang, Y.P., Dakubo, G., Howley, P., Campsall, K.D., Mazarolle, C.J., Shiga, S.A., Lewis, P.M., McMahon, A.P., Wallace, V.A.: Development of normal retinal organization depends on Sonic hedgehog signaling from ganglion cells. Nat. Neurosci. 5, 831–832 (2002)
140. Levine, E.M., Roelink, H., Turner, J., Reh, T.A.: Sonic hedgehog promotes rod photoreceptor differentiation in mammalian retinal cells in vitro. J. Neurosci. 17, 6277– 6288 (1997)
141. Dakubo, G.D., Wang, Y.P., Mazerolle, C., Campsall, K., McMahon, A.P., Wallace, V.A.: Retinal ganglion cellderived sonic hedgehog signaling is required for optic disc and stalk neuroepithelial cell development. Development 130, 2967–2980 (2003)
142. Black, G.C., Mazerolle, C.J., Wang, Y., Campsall, K.D., Petrin, D., Leonard, B.C., Damji, K.F., Evans, D.G., McLeod, D., Wallace, V.A.: Abnormalities of the vitreoretinal interface caused by dysregulated Hedgehog signaling during retinal development. Hum. Mol. Genet. 12, 3269–3276 (2003)
143. Zurawel, R.H., Allen, C., Wechsler-Reya, R., Scott, M.P., Raffel, C.: Evidence that haploinsufficiency of Ptch leads to medulloblastoma in mice. Genes Chromosomes Cancer 28, 77–81 (2000)
144. Milenkovic, L., Goodrich, L.V., Higgins, K.M., Scott, M.P.: Mouse patched1 controls body size determination and limb patterning. Development 126, 4431–4440 (1999)
145. Goodrich, L.V., Milenkovic, L., Higgins, K.M., Scott, M.P.: Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277, 1109–1113 (1997)
146.Goodrich, L.V., Johnson, R.L., Milenkovic, L., McMahon, J.A., Scott, M.P.: Conservation of the hedgehog/patched signaling pathway from flies to mice: induction of a mouse patched gene by Hedgehog. Genes Dev. 10, 301–312 (1996)
147. Zhang, X.M., Yang, X.J.: Temporal and spatial effects of Sonic hedgehog signaling in chick eye morphogenesis. Dev. Biol. 233, 271–290 (2001)
148. Zhang, X.M., Yang, X.J.: Regulation of retinal ganglion cell production by Sonic hedgehog. Development 128, 943–957 (2001)
149. Shkumatava, A., Fischer, S., Muller, F., Strahle, U., Neumann, C.J.: Sonic hedgehog, secreted by amacrine cells, acts as a short-range signal to direct differentiation and lamination in the zebrafish retina. Development 131, 3849–3858 (2004)
150. Moshiri, A., Reh, T.A.: Persistent progenitors at the retinal margin of ptc+/- mice. J. Neurosci. 24, 229–237 (2004)
151. Spence, J.R., Madhavan, M., Ewing, J.D., Jones, D.K., Lehman, B.M., Del Rio-Tsonis, K.: The hedgehog pathway is a modulator of retina regeneration. Development 131, 4607–4621 (2004)
152. Neumann, C.J., Nuesslein-Volhard, C.: Patterning of the zebrafish retina by a wave of sonic hedgehog activity. Science 289, 2137–2139 (2000)
153. Xu, H.E., Rould, M.A., Xu, W., Epstein, J.A., Maas, R.L., Pabo, C.O.: Crystal structure of the human Pax6 paired domain-DNA complex reveals specific roles for the linker region and carboxy-terminal subdomain in DNA binding. Genes Dev. 13, 1263–1275 (1999)
154. Bateson, P.: William Bateson: a biologist ahead of his time. J. Genet. 81, 49–58 (2002)
155. Gillham, N.W.: Evolution by jumps: Francis Galton and William Bateson and the mechanism of evolutionary change. Genetics 159, 1383–1392 (2001)
156. Rubin, G.M., Lewis, E.B.: A brief history of Drosophila’s contributions to genome research. Science 287, 2216–2218 (2000)
157. Lewis, E.B.: The bithorax complex: the first fifty years. Int. J. Dev. Biol. 42, 403–415 (1998)
158. Lewis, E.B.: A gene complex controlling segmentation in Drosophila. Nature 276, 565–570 (1978)
159.Hombria, J.C., Lovegrove, B.: Beyond homeosis–HOX functioninmorphogenesisandorganogenesis.Differentiation 71, 461–476 (2003)
160. Prince, V.: The Hox Paradox: more complex(es) than imagined. Dev. Biol. 249, 1–15 (2002)
161. Finnerty, J.R., Martindale, M.Q.: The evolution of the Hox cluster: insights from outgroups. Curr. Opin. Genet. Dev. 8, 681–687 (1998)
162. Akam, M.: Hox genes: from master genes to micromanagers. Curr. Biol. 8, R676–R678 (1998)
163. Capecchi, M.R.: Hox genes and mammalian development. Cold Spring Harb. Symp. Quant. Biol. 62, 273–281 (1997)
164. Mann, R.S.: Why are Hox genes clustered? Bioessays 19, 661–664 (1997)
165.Duboule, D.: Vertebrate Hox genes and proliferation: an alternative pathway to homeosis? Curr. Opin. Genet. Dev. 5,
525–528 (1995)
166. Ruddle, F.H., Bartels, J.L., Bentley, K.L., Kappen, C., Murtha, M.T., Pendleton, J.W.: Evolution of Hox genes. Annu. Rev. Genet. 28, 423–442 (1994)
167. Tabin, C.J.: Why we have (only) five fingers per hand: hox genes and the evolution of paired limbs. Development 116, 289–296 (1992)
1 Development of the Retina |
33 |
|
|
168. Gehring, W.J.: Exploring the homeobox. Gene 135, 215–221 (1993)
169. Gehring, W.J., Muller, M., Affolter, M., Percival-Smith, A., Billeter, M., Qian, Y.Q., Otting, G., Wuthrich, K.: The structure of the homeodomain and its functional implications. Trends Genet. 6, 323–329 (1990)
170. Gehring, W.J.: The homeobox in perspective. Trends Biochem. Sci. 17, 277–280 (1992)
171. Gehring, W.J., Hiromi, Y.: Homeotic genes and the homeobox. Annu. Rev. Genet. 20, 147–173 (1986)
172. Gehring, W.J.: Homeotic genes, the homeo box, and the genetic control of development. Cold Spring Harb. Symp. Quant. Biol. 50, 243–251 (1985)
173. Gehring, W.J.: The homeo box: a key to the understanding of development? Cell 40, 3–5 (1985)
174. Lewis, E.B.: Regulation of the genes of the bithorax complex in Drosophila. Cold Spring Harb. Symp. Quant. Biol. 50, 155–164 (1985)
175. Christ, B., Schmidt, C., Huang, R., Wilting, J., BrandSaberi, B.: Segmentation of the vertebrate body. Anat. Embryol (Berl). 197, 1–8 (1998)
176. Gilbert, S.A.: Developmental biology. Inauer Associates, Sunderlan, MA (2003)
177. Lewin, B.: Genes VIII. Pearson, Upper Saddle River, NJ (2004)
178. Baldwin, C.T., Hoth, C.F., Macina, R.A., Milunsky, A.: Mutations in PAX3 that cause Waardenburg syndrome type I: ten new mutations and review of the literature. Am. J. Med. Genet. 58, 115–122 (1995)
179. Arias, S.: Waardenburg syndrome–two distinct types. Am. J. Med. Genet. 6, 99–100 (1980)
180. Baldwin, C.T., Lipsky, N.R., Hoth, C.F., Cohen, T., Mamuya, W., Milunsky, A.: Mutations in PAX3 associated with Waardenburg syndrome type I. Hum. Mutat. 3, 2 05–211 (1994)
181. Tassabehji, M., Read, A.P., Newton, V.E., Harris, R., Balling, R., Gruss, P., Strachan, T.: Waardenburg’s syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature 355, 635–636 (1992)
182. Tassabehji, M., Read, A.P., Newton, V.E., Patton, M., Gruss, P., Harris, R., Strachan, T.: Mutations in the PAX3 gene causing Waardenburg syndrome type 1 and type 2. Nat. Genet. 3, 26–30 (1993)
183. Tremblay, P., Gruss, P.: Pax: genes for mice and men. Pharmacol. Ther. 61, 205–226 (1994)
184. Jordan, T., Hanson, I., Zaletayev, D., Hodgson, S., Prosser, J., Seawright, A., Hastie, N., van Heyningen, V.: The human PAX6 gene is mutated in two patients with aniridia. Nat. Genet. 1, 328–332 (1992)
185. Glaser, T., Walton, D.S., Maas, R.L.: Genomic structure, evolutionary conservation and aniridia mutations in the human PAX6 gene. Nat. Genet. 2, 232–239 (1992)
186. Hanson, I.M , Fletcher, J.M., Jordan, T., Brown, A., Taylor, D., Adams, R.J., Punnett, H.H., van Heyningen, V.: Mutations at the PAX6 locus are found in heterogeneous anterior segment malformations including Peters’ anomaly. Nat. Genet. 6, 168–173 (1994)
187. Churchill, A.J., Booth, A.P., Anwar, R., Markham, A.F.: PAX 6 is normal in most cases of Peters’ anomaly. Eye 12(Pt 2), 299–303 (1998)
188. Dahl, E., Koseki, H., Balling, R.: Pax genes and organogenesis. Bioessays 19, 755–765 (1997)
189. Sanyanusin, P., Schimmenti, L.A., McNoe, L.A., Ward, T.A., Pierpont, M.E., Sullivan, M.J., Dobyns, W.B., Eccles, M.R.: Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nat. Genet. 9, 358–364 (1995)
190. Sanyanusin, P., McNoe, L.A., Sullivan, M.J., Weaver, R.G., Eccles, M.R.: Mutation of PAX2 in two siblings with renalcoloboma syndrome. Hum. Mol. Genet. 4, 2183–2184 (1995)
191. Dureau, P., Attie-Bitach, T., Salomon, R., Bettembourg, O., Amiel, J., Uteza, Y., Dufier, J.L.: Renal coloboma syndrome. Ophthalmology 108, 1912–1916 (2001)
192. Chung, G.W., Edwards, A.O., Schimmenti, L.A., Manligas, G.S., Zhang, Y.H., Ritter 3rd, R.: Renal-coloboma syndrome: report of a novel PAX2 gene mutation. Am. J. Ophthalmol. 132, 910–914 (2001)
193. Schimmenti, L.A., Cunliffe, H.E., McNoe, L.A., Ward, T.A., French, M.C., Shim, H.H., Zhang, Y.H., Proesmans, W., Leys, A., Byerly, K.A., et al.: Further delineation of renalcoloboma syndrome in patients with extreme variability of phenotype and identical PAX2 mutations. Am. J. Hum. Genet. 60, 869–878 (1997)
194. Wehr, R., Gruss, P.: Pax and vertebrate development. Int. J. Dev. Biol. 40, 369–377 (1996)
195. Steel, K.P., Smith, R.J.: Normal hearing in Splotch (Sp/+), the mouse homologue of Waardenburg syndrome type 1. Nat. Genet. 2, 75–79 (1992)
196. Pilz, A.J., Povey, S., Gruss, P., Abbott, C.M.: Mapping of the human homologs of the murine paired-box-containing genes. Mamm. Genome 4, 78–82 (1993)
197. Chalepakis, G., Stoykova, A., Wijnholds, J., Tremblay, P., Gruss, P.: Pax: gene regulators in the developing nervous system. J. Neurobiol. 24, 1367–1384 (1993)
198. Hill, R.E., Favor, J., Hogan, B.L., Ton, C.C., Saunders, G.F., Hanson, I.M., Prosser, J., Jordan, T., Hastie, N.D., van Heyningen, V.: Mouse small eye results from mutations in a paired-like homeobox-containing gene. Nature 354, 522–525 (1991)
199. Quiring, R., Walldorf, U., Kloter, U., Gehring, W.J.: Homology of the eyeless gene of Drosophila to the Small eye gene in mice and Aniridia in humans. Science 265, 785–789 (1994)
200. Enwright 3rd, J.F., Grainger, R.M.: Altered retinoid signaling in the heads of small eye mouse embryos. Dev. Biol. 221, 10–22 (2000)
201. Schmahl, W., Knoedlseder, M., Favor, J., Davidson, D.: Defects of neuronal migration and the pathogenesis of cortical malformations are associated with Small eye (Sey) in the mouse, a point mutation at the Pax-6-locus. Acta Neuropathol (Berl). 86, 126–135 (1993)
202. Matsuo, T., Osumi-Yamashita, N., Noji, S., Ohuchi, H., Koyama, E., Myokai, F., Matsuo, N., Taniguchi, S., Doi, H., Iseki, S., et al.: A mutation in the Pax-6 gene in rat small eye is associated with impaired migration of midbrain crest cells. Nat. Genet. 3, 299–304 (1993)
203. Mansouri, A., Stoykova, A., Gruss, P.: Pax genes in development. J. Cell Sci. Suppl. 18, 35–42 (1994)
204. Mansouri, A., Goudreau, G., Gruss, P.: Pax genes and their role in organogenesis. Cancer Res. 59, 1707s–1709s; discussion 1709s–1710s (1999)
34 |
F. Gonzalez-Fernandez |
|
|
205. Strachan, T., Read, A.P.: PAX genes. Curr. Opin. Genet. Dev. 4, 427–438 (1994)
206. Kim, A.S., Anderson, S A., Rubenstein, J.L , Lowenstein, D.H., Pleasure, S.J.: Pax-6 regulates expression of SFRP-2 and Wnt-7b in the developing CNS. J. Neurosci. 21, RC132 (2001)
207. Noramly, S., Grainger, R.M.: Determination of the embryonic inner ear. J. Neurobiol. 53, 100–128 (2002)
208. Scotting, P.J., Rex, M.: Transcription factors in early development of the central nervous system. Neuropathol. Appl. Neurobiol. 22, 469–481 (1996)
209. Christ, B., Huang, R., Wilting, J.: The development of the avian vertebral column. Anat. Embryol (Berl). 202, 179–194 (2000)
210. Nilsson, D.E.: Eye ancestry: old genes for new eyes. Curr. Biol. 6, 39–42 (1996)
211. Fernald, R.D.: Evolution of eyes. Curr. Opin. Neurobiol. 10, 444–450 (2000)
212. Fernald, R.D.: The evolution of eyes. Brain. Behav. Evol. 50, 253–259 (1997)
213. Gehring, W.J.: The master control gene for morphogenesis and evolution of the eye. Genes Cells 1, 11–15 (1996)
214. Halder, G., Callaerts, P., Flister, S., Walldorf, U., Kloter, U., Gehring, W.J.: Eyeless initiates the expression of both sine oculis and eyes absent during Drosophila compound eye development. Development 125, 2181–2191 (1998)
215. Halder, G., Callaerts, P., Gehring, W.J.: Induction of ectopic eyes by targeted expression of the eyeless gene in Drosophila. Science 267, 1788–1792 (1995)
216. Gehring, W.J., Ikeo, K.: Pax 6: mastering eye morphogenesis and eye evolution. Trends Genet. 15, 371–377 (1999)
217. Callaerts, P., Halder, G., Gehring, W.J.: PAX-6 in development and evolution. Annu. Rev. Neurosci. 20, 483–532 (1997)
218. Pichaud, F., Treisman, J., Desplan, C.: Reinventing a common strategy for patterning the eye. Cell 105, 9–12 (2001)
219. Pichaud, F., Desplan, C.: Pax genes and eye organogenesis. Curr. Opin. Genet. 12, 430–434 (2002)
220.David, J.R.: Evolution and development: some insights from evolutionary theory. An. Acad. Bras. Cienc. 73, 385 –395 (2001)
221. Glardon, S., Callaerts, P., Halder, G., Gehring, W.J.: Conservation of Pax-6 in a lower chordate, the ascidian Phallusia mammillata. Development 124, 817–825 (1997)
222. Sun, H., Rodin, A., Zhou, Y., Dickinson, D.P., Harper, D.E., Hewett-Emmett, D., Li, W.H.: Evolution of paired domains: isolation and sequencing of jellyfish and hydra Pax genes related to Pax-5 and Pax-6. Proc. Natl. Acad. Sci. USA 94, 5156–5161 (1997)
223. Kozmik, Z., Holland, N.D., Kalousova, A., Paces, J., Schubert, M., Holland, L.Z.: Characterization of an amphioxus paired box gene, AmphiPax2/5/8: developmental expression patterns in optic support cells, nephridium, thyroid-like structures and pharyngeal gill slits, but not in the midbrain-hindbrain boundary region. Development 126, 1295–1304 (1999)
224. Glardon, S., Holland, L.Z., Gehring, W.J., Holland, N.D.: Isolation and developmental expression of the amphioxus Pax-6 gene (AmphiPax-6): insights into eye and photoreceptor evolution. Development 125, 2701–2710 (1998)
225. Rabl, C.: Uber den Bau und die Entwicklung der Linse. I. Selachier und Amphibien. Ztschr f wiss Z Zool 63, 496–572 (1898)
226. Jacobson, A.G., Sater, A.K.: Features of embryonic induction. Development 104, 341–359 (1988)
227. Lopashov, G.V., Zemchikhina, V.N.: Hierarchy of inductive events. Dev. Growth Differ. 39, 661–665 (1997)
228. McAvoy, J.W., Chamberlain, C.G., de Iongh, R.U., Richardson, N.A., Lovicu, F.J.: The role of fibroblast growth factor in eye lens development. Ann. N. Y. Acad. Sci. 638, 256–274 (1991)
229. McAvoy, J.W, Chamberlain, C.G., de Iongh, R.U., Hales, A.M., Lovicu, F.J.: Lens development. Eye 13(Pt 3b), 425–437 (1999)
230. de Iongh, R., McAvoy, J.W.: Spatio-temporal distribution of acidic and basic FGF indicates a role for FGF in rat lens morphogenesis. Dev. Dyn. 198, 190–202 (1993)
231. Hyer, J., Mima, T., Mikawa, T.: FGF1 patterns the optic vesicle by directing the placement of the neural retina domain. Development 125, 869–877 (1998)
232. Park, C.M., Hollenberg, M.J.: Basic fibroblast growth factor induces retinal regeneration in vivo. Dev. Biol. 134, 201–205 (1989)
233. Hyer, J., Kuhlman, J., Afif, E., Mikawa, T.: Optic cup morphogenesis requires pre-lens ectoderm but not lens differentiation. Dev. Biol. 259, 351–363 (2003)
234. Cuenot, L.: Regeneration de pattes a la place d’antennes sectionnees chezun Phasme. Compets. Rendus. Acad. Sci. Paris 172, 949–952 (1921)
235. Mic, F.A., Molotkov, A., Molotkova, N., Duester, G.: Raldh2 expression in optic vesicle generates a retinoic acid signal needed for invagination of retina during optic cup formation. Dev. Dyn. 231, 270–277 (2004)
236. Fan, X., Molotkov, A., Manabe, S., Donmoyer, C.M., Deltour, L., Foglio, M.H., Cuenca, A.E., Blaner, W.S., Lipton, S.A., Duester, G.: Targeted disruption of Aldh1a1 (Raldh1) provides evidence for a complex mechanism of retinoic acid synthesis in the developing retina. Mol. Cell Biol. 23, 4637–4648 (2003)
237. Schmitt, E.A., Dowling, J.E.: Early eye morphogenesis in the zebrafish, Brachydanio rerio. J. Comp. Neurol. 344, 532–542 (1994)
238. Martinez-Morales, J.R., Rodrigo, I., Bovolenta, P.: Eye development: a view from the retina pigmented epithelium. Bioessays 26, 766–777 (2004)
239. Zuber, M.E., Gestri, G., Viczian, A.S., Barsacchi, G., Harris, W.A.: Specification of the vertebrate eye by a network of eye field transcription factors. Development 130, 5155–5167 (2003)
240. Pittack, C., Grunwald, G.B., Reh, T.A.: Fibroblast growth factors are necessary for neural retina but not pigmented epithelium differentiation in chick embryos. Development 124, 805–816 (1997)
241. Pittack, C., Jones, M., Reh, T.A.: Basic fibroblast growth factor induces retinal pigment epithelium to generate neural retina in vitro. Development 113, 577–588 (1991)
242.Fuhrmann, S., Levine, E.M., Reh, T.A.: Extraocular mesenchyme patterns the optic vesicle during early eye development in the embryonic chick. Development 127, 4599–4609 (2000)
1 Development of the Retina |
35 |
|
|
243. Belecky-Adams, T.L., Scheurer, D., Adler, R.: Activin family members in the developing chick retina: expression patterns, protein distribution, and in vitro effects. Dev. Biol. 210, 107–123 (1999)
244. Davis, A.A., Matzuk, M.M., Reh, T.A.: Activin A promotes progenitor differentiation into photoreceptors in rodent retina. Mol. Cell Neurosci. 15, 11–21 (2000)
245. Goding, C.R.: Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. Genes Dev. 14, 1712–1728 (2000)
246. Tachibana, M.: MITF: a stream flowing for pigment cells. Pigment Cell Res. 13, 230–240 (2000)
247. Tachibana, M., Kobayashi, Y., Matsushima, Y.: Mouse models for four types of Waardenburg syndrome. Pigment Cell Res. 16, 448–454 (2003)
248. Tachibana, M.: A cascade of genes related to Waardenburg syndrome. J. Investig. Dermatol. Symp. Proc. 4, 126–129 (1999)
249.Tachibana,M.,Perez-Jurado,L.A.,Nakayama,A.,Hodgkinson, C.A., Li, X., Schneider, M., Miki, T., Fex, J., Francke, U., Arnheiter, H.: Cloning of MITF, the human homolog of the mouse microphthalmia gene and assignment to chromosome 3p14.1-p12.3. Hum. Mol. Genet. 3, 553–557 (1994)
250. Horsford, D.J., Nguyen, M.T., Sellar, G.C., Kothary, R., Arnheiter, H., McInnes, R.R.: Chx10 repression of Mitf is required for the maintenance of mammalian neuroretinal identity. Development 132, 177–187 (2005)
251. Ferda Percin, E., Ploder, L.A , Yu, J.J., Arici, K., Horsford, D.J., Rutherford, A., Bapat, B., Cox, D.W., Duncan, A.M., Kalnins, V.I., et al.: Human microphthalmia associated with mutations in the retinal homeobox gene CHX10. Nat. Genet. 25, 397–401 (2000)
252. Bok, D.: Retinal photoreceptor-pigment epithelium interactions. Friedenwald lecture. Invest. Ophthalmol. Vis. Sci. 26, 1659–1694 (1985)
253. Bok, D.: The retinal pigment epithelium: a versatile partner in vision. J. Cell Sci. Suppl. 17, 189–195 (1993)
254. Mieziewska, K.: The interphotoreceptor matrix, a space in sight. Microsc. Res. Tech. 35, 463–471 (1996)
255. Hageman, G.S., Johnson, L.V.: Structure, composition and function of the retinal interphotoreceptor matrix. Prog. Ret. Res. 10, 207–249 (1991)
256. Hageman, G.S., Kuehn, M.H.: Biology of the interphotoreceptor matrix-retinal interface. In: Marmor, M.F., Wolfensberber, T.J. (eds.) The retinal pigment epithelium, pp. 361–391. Oxford University, New York (1998)
257. Hageman, G.S., Kirchoff-Rempe, M.A., Lewis, G.P., Fisher, S.K., Anderson, D.H.: Sequestration of basic fibroblast growth factor in the primate retinal interphotoreceptor matrix. Proc. Natl. Acad. Sci. USA 88, 6706–6710 (1991)
258. Hewitt, A.T., Lindsey, J.D., Carbott, D., Adler, R.: Photoreceptor survival-promoting activity in interphotoreceptor matrix preparations: characterization and partial purification. Exp. Eye Res. 50, 79–88 (1990)
259. Plantner, J.J., Smine, A., Quinn, T.A.: Matrix metalloproteinases and metalloproteinase inhibitors in human interphotoreceptor matrix and vitreous. Curr. Eye Res. 17, 132–140 (1998)
260. Hollyfield, J.G.: Hyaluronan and the functional organization of the interphotoreceptor matrix. Invest. Ophthalmol. Vis. Sci. 40, 2767–2769 (1999)
261. Kuehn, M.H., Hageman, G.S.: Expression and characterization of the IPM 150 gene (IMPG1) product, a novel human photoreceptor cell-associated chondroitin-sulfate proteoglycan. Matrix Biol. 18, 509–518 (1999)
262. Hollyfield, J.G., Witkovsky, P.: Pigmented retinal epithelium involvement in photoreceptor development and function. J. Exp. Zool. 189, 357–378 (1974)
263. Stiemke, M M., Landers, R.A., al-Ubaidi, M.R., Rayborn, M.E., Hollyfield, J.G.: Photoreceptor outer segment development in Xenopus laevis: influence of the pigment epithelium. Dev. Biol. 162, 169–180 (1994)
264. Carter-Dawson, L., Burroughs, M.: Differential distribution of interphotoreceptor retinoid-binding protein (IRBP) around retinal rod and cone photoreceptors. Curr. Eye Res. 8, 1331–1334 (1989)
265. Eisenfeld, A.J., Bunt-Milam, A.H., Saari, J.C.: Localization of retinoid-binding proteins in developing rat retina. Exp. Eye Res. 41, 299–304 (1985)
266. Gonzalez-Fernandez, F., Healy, J.I.: Early expression of the gene for interphotoreceptor retinol-binding protein during photoreceptor differentiation suggests a critical role for the interphotoreceptor matrix in retinal development. J. Cell Biol. 111, 2775–2784 (1990)
267. Hauswirth, W.W., Langerijt, A.V., Timmers, A M., Adamus, G., Ulshafer, R.J.: Early expression and localization of rhodopsin and interphotoreceptor retinoid-binding protein (IRBP) in the developing fetal bovine retina. Exp. Eye Res. 54, 661–670 (1992)
268. Heussler, H.S., Suri, M., Young, I.D., Muenke, M.: Extreme variability of expression of a Sonic Hedgehog mutation: attention difficulties and holoprosencephaly. Arch. Dis. Child. 86, 293–296 (2002)
269. Herr, F.M., Matarese, V., Bernlohr, D.A., Storch, J.: Surface lysine residues modulate the collisional transfer of fatty acid from adipocyte fatty acid binding protein to membranes. Biochemistry 34, 11840–11845 (1995)
270. DesJardin, L.E., Timmers, A.M., Hauswirth, W.W.: Tran scription of photoreceptor genes during fetal retinal development. Evidence for positive and negative regulation. J. Biol. Chem. 268, 6953–6960 (1993)
271. Gonzalez-Fernandez, F., Van Niel, E., Edmonds, C., Beaver, H., Nickerson, J.M., Garcia-Fernandez, J.M., Campohiaro, P.A., Foster, R.G.: Differential expression of interphotoreceptor retinoid-binding protein, opsin, cellular retinaldehydebinding protein, and basic fibroblastic growth factor. Exp. Eye Res. 56, 411–427 (1993)
272. Liou, G.I., Wang, M., Matragoon, S.: Precocious IRBP gene expression during mouse development. Invest. Ophthalmol. Vis. Sci. 35, 1083–1088 (1994)
273. Liou, G.I., Wang, M., Matragoon, S.: Timing of interphotoreceptor retinoid-binding protein (IRBP) gene expression and hypomethylation in developing mouse retina. Dev. Biol. 161, 345–356 (1994)
274. Liou, G.I., Matragoon, S., Chen, D.M., Gao, C.L., Zhang, L., Fei, Y., Katz, M.L., Stark, W.S.: Visual sensitivity and interphotoreceptor retinoid binding protein in the mouse: regulation by vitamin A. FASEB. J. 12, 129–138 (1998)
275.Hessler, R.B., Baer, C.A., Bukelman, A., Kittredge, K.L., Gonzalez-Fernandez, F.: Interphotoreceptor retinoid-binding protein (IRBP): expression in the adult and developing Xenopus retina. J. Comp. Neurol. 367, 329–341 (1996)
36 |
F. Gonzalez-Fernandez |
|
|
276. Zhu, L., Skoultchi, A.I.: Coordinating cell proliferation and differentiation. Curr. Opin. Genet. Dev. 11, 91–97 (2001)
277. Dyer, M.A., Cepko, C.L.: Regulating proliferation during retinal development. Nat. Rev. Neurosci. 2, 333–342 (2001)
278. Turner, D.L., Cepko, C.L.: A common progenitor for neurons and glia persists in rat retina late in development. Nature 328, 131–136 (1987)
279. Cepko, C.L., Ryder, E., Austin, C., Golden, J., FieldsBerry, S., Lin, J.: Lineage analysis using retroviral vectors. Methods 14, 393–406 (1998)
280. Rapaport, D.H., Wong, L.L., Wood, E.D., Yasumura, D., LaVail, M.M.: Timing and topography of cell genesis in the rat retina. J. Comp. Neurol. 474, 304–324 (2004)
281. Livesey, F.J., Cepko, C.L.: Vertebrate neural cell-fate determination: lessons from the retina. Nat. Rev. Neurosci. 2, 109–118 (2001)
282. Young, R.W.: Cell proliferation during postnatal development of the retina in the mouse. Brain Res. 353, 229–239 (1985)
283. Young, R.W.: Cell differentiation in the retina of the mouse. Anat. Rec. 212, 199–205 (1985)
284. Wetts, R., Fraser, S.E.: Multipotent precursors can give rise to all major cell types of the frog retina. Science 239, 1142–1145 (1988)
285. Holt, C.E., Bertsch, T.W., Ellis, H.M., Harris, W.A.: Cellular determination in the Xenopus retina is independent of lineage and birth date. Neuron 1, 15–26 (1988)
286. Fekete, D.M., Perez-Miguelsanz, J., Ryder, E.F., Cepko, C.L.: Clonal analysis in the chicken retina reveals tangential dispersion of clonally related cells. Dev. Biol. 166, 666–682 (1994)
287. Cepko, C.L., Austin, C.P., Yang, X., Alexiades, M., Ezzeddine, D.: Cell fate determination in the vertebrate retina. Proc. Natl. Acad. Sci. USA 93, 589–595 (1996)
288. Adler, R., Hatlee, M.: Plasticity and differentiation of embryonic retinal cells after terminal mitosis. Science 243, 391–393 (1989)
289. Sparrow, J.R., Hicks, D., Barnstable, C.J.: Cell commitment and differentiation in explants of embryonic rat neural retina. Comparison with the developmental potential of dissociated retina. Brain Res. Dev. Brain Res. 51, 69–84 (1990)
290. Reh, T.A.: Cellular interactions determine neuronal phenotypes in rodent retinal cultures. J. Neurobiol. 23, 1067– 1083 (1992)
291. Watanabe, T., Raff, M.C.: Rod photoreceptor development in vitro: intrinsic properties of proliferating neuroepithelial cells change as development proceeds in the rat retina. Neuron 4, 461–467 (1990)
292. Cepko, C.L.: The roles of intrinsic and extrinsic cues and bHLH genes in the determination of retinal cell fates. Curr. Opin. Neurobiol. 9, 37–46 (1999)
293. Altshuler, D., Lo Turco, J.J., Rush, J., Cepko, C.: Taurine promotes the differentiation of a vertebrate retinal cell type in vitro. Development 119, 1317–1328 (1993)
294. Altshuler, D., Cepko, C.: A temporally regulated, diffusible activity is required for rod photoreceptor development in vitro. Development 114, 947–957 (1992)
295.Cepko, C.L.: The patterning and onset of opsin expression in vertebrate retinae. Curr. Opin. Neurobiol. 6, 542–546 (1996)
296. Daniels, M., Dhokia, V., Richard-Parpaillon, L., Ohnuma, S.: Identification of Xenopus cyclin-dependent kinase inhibitors, p16Xic2 and p17Xic3. Gene 342, 41–47 (2004)
297. Yang, Z., Ding, K., Pan, L., Deng, M., Gan, L.: Math5 determines the competence state of retinal ganglion cell progenitors. Dev. Biol. 264, 240–254 (2003)
298. Levine, E.M., Close, J., Fero, M., Ostrovsky, A., Reh, T.A.: p27(Kip1) regulates cell cycle withdrawal of late multipotent progenitor cells in the mammalian retina. Dev. Biol. 219, 299–314 (2000)
299. Dyer, M.A., Cepko, C.L.: p27Kip1 and p57Kip2 regulate proliferation in distinct retinal progenitor cell populations. J. Neurosci. 21, 4259–4271 (2001)
300. Dyer, M.A., Cepko, C.L.: p57(Kip2) regulates progenitor cell proliferation and amacrine interneuron development in the mouse retina. Development 127, 3593–3605 (2000)
301. Morrow, E.M., Belliveau, M.J., Cepko, C.L.: Two phases of rod photoreceptor differentiation during rat retinal development. J. Neurosci. 18, 3738–3748 (1998)
302. Zhang, J., Gray, J., Wu, L., Leone, G., Rowan, S., Cepko, C.L., Zhu, X., Craft, C.M., Dyer, M.A.: Rb regulates proliferation and rod photoreceptor development in the mouse retina. Nat. Genet. 36, 351–360 (2004)
303. Levine, E.M., Green, E.S.: Cell-intrinsic regulators of proliferation in vertebrate retinal progenitors. Semin. Cell Dev. Biol. 15, 63–74 (2004)
304. Dyer, M.A., Livesey, F.J., Cepko, C.L., Oliver, G.: Prox1 function controls progenitor cell proliferation and horizontal cell genesis in the mammalian retina. Nat. Genet. 34, 53–58 (2003)
305. Rehen, S.K., Cid, M., Fragel-Madeira, L., Linden, R.: Differential effects of cyclin-dependent kinase blockers upon cell death in the developing retina. Brain Res. 947, 78–83 (2002)
306. Vincent, M.C., Gallai, R., Olivier, D., Speeg-Schatz, C., Flament, J., Calvas, P., Dollfus, H.: Variable phenotype related to a novel PAX 6 mutation (IVS4+5G>C) in a family presenting congenital nystagmus and foveal hypoplasia. Am. J. Ophthalmol. 138, 1016–1021 (2004)
307. Azuma, N.: Molecular cell biology on morphogenesis of the fovea and evolution of the central vision. Nippon Ganka Gakkai Zasshi 104, 960–985 (2000)
308. Ohba, N.: Introduction to genetics in ophthalmology, value of family studies. Jpn. J. Ophthalmol. 44, 320–321 (2000)
309.Hendrickson, A.E.: Primate foveal development: a microcosmofcurrentquestionsinneurobiology.Invest.Ophthalmol. Vis. Sci. 35, 3129–3133 (1994)
310. Provis, J.M.: Development of the primate retinal vasculature. Prog. Retin. Eye Res. 20, 799–821 (2001)
311. Hendrickson, A.E., Yuodelis, C.: The morphological development of the human fovea. Ophthalmology 91, 603–612 (1984)
312. Hendrickson, A., Kupfer, C.: The histogenesis of the fovea in the macaque monkey. Invest. Ophthalmol. Vis. Sci. 15, 746–756 (1976)
313. Provis, J.M., van Driel, D., Billson, F.A., Russell, P.: Development of the human retina: patterns of cell distribution and redistribution in the ganglion cell layer. J. Comp. Neurol. 233, 429–451 (1985)
314. van Driel, D., Provis, J.M., Billson, F.A.: Early differentiation of ganglion, amacrine, bipolar, and Muller cells in the
1 Development of the Retina |
37 |
|
|
developing fovea of human retina. J. Comp. Neurol. 291, 203–219 (1990)
315. Curcio, C.A., Sloan, K.R., Kalina, R.E., Hendrickson, A.E.: Human photoreceptor topography. J. Comp. Neurol. 292, 497–523 (1990)
316. Hendrickson, A., Drucker, D.: The development of parafoveal and mid-peripheral human retina. Behav. Brain Res. 49, 21–31 (1992)
317. Provis, J.M., Diaz, C.M., Dreher, B.: Ontogeny of the primate fovea: a central issue in retinal development. Prog. Neurobiol. 54, 549–580 (1998)
318. Georges, P., Madigan, M.C., Provis, J.M.: Apoptosis during development of the human retina: relationship to foveal development and retinal synaptogenesis. J. Comp. Neurol. 413, 198–208 (1999)
319. Diaz-Araya, C., Provis, J.M.: Evidence of photoreceptor migration during early foveal development: a quantitative analysis of human fetal retinae. Vis. Neurosci. 8, 505–514 (1992)
320. Engerman, R.L.: Development of the macular circulation. Invest. Ophthalmol. 15, 835–840 (1976)
321.Gariano, R.F., Provis,J.M., Hendrickson,A.E.:Development of the foveal avascular zone. Ophthalmology 2000, 107 (1026)
322. Gariano, R.F., Sage, E.H., Kaplan, H.J., Hendrickson, A.E.: Development of astrocytes and their relation to blood vessels in fetal monkey retina. Invest. Ophthalmol. Vis. Sci. 37, 2367–2375 (1996)
323. Sandercoe, T.M., Geller, S.F., Hendrickson, A.E., Stone, J., Provis, J.M.: VEGF expression by ganglion cells in central retina before formation of the foveal depression in monkey retina: evidence of developmental hypoxia. J. Comp. Neurol. 462, 42–54 (2003)
324. Springer, A.D., Hendrickson, A.E.: Development of the primate area of high acuity. 1. Use of finite element analysis models to identify mechanical variables affecting pit formation. Vis. Neurosci. 21, 53–62 (2004)
325. Yuodelis, C., Hendrickson, A.: A qualitative and quantitative analysis of the human fovea during development. Vision Res. 26, 847–855 (1986)
326. Provis, J.M., Penfold, P.L.: Cell death and the elimination of retinal axons during development. Prog. Neurobiol. 31, 331–347 (1988)
327. Duke-Elder, S.: The eye in evolution. C.V. Mosby, St. Louis (1958)
328. Spemann, H.: Zur Entwicklung des Wirbeltierauges. Zool Jahrb Abt F allg Zool u Phys d Tiere 32, 1–98 (1912)
329. Cook, T.: Cell diversity in the retina: more than meets the eye. Bioessays 25, 921–925 (2003)
330. De Leeuw, A.M., Gaur, V.P., Saari, J.C., Milam, A.H.: Immunolocalization of cellular retinol-, retinaldehydeand retinoic acid-binding proteins in rat retina during preand postnatal development. J. Neurocytol. 19, 253–264 (1990)
331. Eisenfeld, A.J., Bunt-Milam, A.H., Saari, J.C.: Immunocy tochemical localization of retinoid-binding proteins in developing normal and RCS rats. Prog. Clin. Biol. Res. 190, 231–240 (1985)
332. Saari, J.C., Bunt-Milam, A.H., Bredberg, D.L., Garwin, G.G.: Properties and immunocytochemical localization of three retinoid-binding proteins from bovine retina. Vision Res. 24, 1595–1603 (1984)
333. Bunt-Milam, A.H., Saari, J.C.: Immunocytochemical localization of two retinoid-binding proteins in vertebrate retina. J. Cell Biol. 97, 703–712 (1983)
334. Hogan, M.: Histology of the human eye. W.B. Saunders, Philadelphia (1971)
335. Krebs, I.P., Krebs, W.: Discontinuities of the external limiting membrane in the fovea centralis of the primate retina. Exp. Eye Res. 48, 295–301 (1989)
336. Bunt-Milam, A.H., Saari, J.C., Klock, I.B., Garwin, G.G.: Zonulae adherentes pore size in the external limiting membrane of the rabbit retina. Invest. Ophthalmol. Vis. Sci. 26, 1377–1380 (1985)
337. Stanton, B.Z., Peng, L.F. : Small-molecule modulators of the Sonic Hedgehog signaling pathway. Mol Biosyst. 6, 44–54 (2010).
338.Ogino, H., M. Fisher, and Grainger, R.M.: Convergence of a head-field selector Otx2 and Notch signaling: a mechanism for lens specification. Development 135, 249–258 (2008)
